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ABSTRACT 
 
The ongoing advance of high-throughput sequencing technologies is bringing to the biomedical 
research community the opportunity to disclose relatively uncharted and poorly addressed 
domains in genetic disorders. Specifically, this project aims to shed new light on the molecular 
mechanisms of three rare skin diseases: Recessive Dystrophic Epidermolysis Bullosa (RDEB), 
Kindler Syndrome (KS) and Xeroderma pigmentosum type C (XPC). To accomplish this, biological 
network construction is leveraged herein, by providing a convenient approach to integrate and 
downstream analyze molecular omics data obtained from the comparison of these three 
genodermatoses (RDEB, KS & XPC) against healthy control samples. Concretely, microRNAs, 
RNAs and protein datasets are conjointly combined in the form of graphs whose structure and 
arrangement can be analyzed. On this basis, and upon computational procedures, the 
representation of high-throughput omics data across networks serves for both a topological and 
functional characterization of the molecular entities embedded within the graphs. Cytoscape 
software harbors the toolkits needed to exploit the massive omics information presented in this 
work, closely operating with online ontologies containing crucial annotations on the molecular 
entities under the network conglomerates. Cytoscape platform is going to carry out the 
bioinformatics computational endeavours, conducting then to new insights where common 
mechanisms and candidate biomarkers shared by the three genodermatoses will be highlighted. 
In this manner, STRING, BiNGO and ClueGO (Cytoscape plug-ins) will assist in the finding of 
enriched functions (such as “cell adhesions” and “epidermal growth factor signaling”), whereas 
the topological analysis will rely on STRING and NetworkAnalyzer, following the principles of 
graph theory to identify candidate molecules like TFAP2A and L1CAM. With the aid of manual 
curations, these two approaches will stand for a narrowing-down strategy from which biological 
interpretations are obtained. 
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1. INTRODUCTION 
 a. Systems Biology and Network Medicine 
 
Systems Biology is an emerging inter-disciplinary field which makes use of advanced 
technologies to carry out cutting-edge computational analyses with the aim of unraveling deep 
biological knowledge [1]. System Biology offers an approach complementary to traditional 
molecular biology by considering the interrelationships between the components of the cell, the 
potential emerging properties and treating the cell as an integrated system. Next-generation 
sequencing technologies (NGS) allow a rapid and effective breakthrough to the field of genomic 
research. Genomic sequencing projects have brought to the scientific community a massive 
amount of high-throughput (HT) data over the last ten years since the completion of the Human 
Genome Project [2]. It has become a well-established and standard technique, which generates 
enormous amounts of biological information. An ample range of instrumentation can be used 
to quantify and characterize different molecules within cells and tissues. NGS platforms stand 
as a crucial procedure for the comprehensive understanding of the mechanisms that comprise 
the living organism phenomena and are therefore essential tools in the field of System Biology 
in order to obtain the necessary data that can be used for modelling the cell response to 
different stimulus. 
Research laboratories are taking advantage of the high potential of these technologies. Thanks 
to the technological improvement, clinical investigations are catching up with desktop 
sequencers. However, this exponential escalation is generating a vast number of sequences 
from different organisms, tissues, conditions etc, leading to tons of gigabytes which need to be 
successfully analysed. In order to give an appropriate biological interpretation to the different 
mechanisms and pathways that conform the functioning of a given organism, the sequenced 
data must be thoroughly analysed, solving the bioinformatics bottle-neck that is impeding to 
study the applications of NGS [3]. 
Even though NGS data is promising and can generate crucial information for the implementation 
of Systems Biology, the current data portals are extremely fragmented. Data integration is giving 
its first steps and there is still a long way to go in terms of workflow unification, tool and software 
development. This issue is causing the researchers to struggle when it comes to going through 
the generated information and employing it for downstream research. Several online platforms 
offer material retrieved from different experiments in a disordered and difficult to understand 
way, causing ambiguity and inefficiency. To prevent this, several repositories are collecting not 
only the data but also the experimental design. However, there is no consensus yet in terms of 
data sharing.  
The solution lies in passing through the “analysis bottle-neck”, building up a unified platform 
where the content is easily accessed and managed [4]. Here is where the role of bioinformatics 
comes in. The in silico interplay between NGS and informatics databases and repositories will 
definitely assist in handling high-throughput (HT) data. 
An efficient storage, sharing and post-processing of NGS data will enable the study of human 
diseases and model organisms through a variety of frameworks, being the so-called biological 
networks the most notorious and suitable one [5]. Essentially, these networks are biological 
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models represented by graphs where the connected entities stand for some phenomenon. 
Namely, the physical entities (in our case, the molecules of interest are represented by nodes in 
the network) are connected by some type of interaction between them (edges), and among the 
rest of the network. 
Even though biological networks are recognized as a disruptive method that will shed some light 
on the biomedical interpretation of data, systems medicine encounters difficulties to explain 
some pathogenesis that have not been addressed in previous investigations yet. This presents a 
shifting of the classical molecular biology reductionist approach towards the integrated holism 
proposed by system biology [6]. So far, many health conditions have been successfully 
diagnosed and treated using the methodological reductionism bases. It basically defends that, 
the small parts of a system -its isolated molecules- can be pieced together by the sum of all its 
physics and chemistry, starting from the simplest level and working upwards the whole 
organization. Reductionism, epitomized by molecular biology in the 20th century [7], has 
thrivingly served to give a strong and valid scientific explanation to numerous diseases and 
mechanisms, especially those based on single gene mutations.  
The debate escalates with the Systems Biology apogee, increasingly cited and referenced in 
many review articles regarding disease pathology. Likewise, complex traits need a 
complementary insight, because reductionism cannot explain the system mechanisms as a 
whole [8]. In this way, holism appears as an integrative approach where the global properties of 
the system -emerging from their interactions- are studied rather than each constituent part. 
Systems are deterministic, but cannot be forecasted – the whole is greater than the sum of its 
parts.  Just to take a clear example, the behaviour of a water molecule cannot be deduced simply 
from the behaviour of oxygen and hydrogen. What is more, the behaviour of water cannot be 
deduced from a single water molecule. Properties like flow and expansion cannot be attributed 
to single molecules.  
Despite their conflicting nature, the evolution of these approaches cannot take place unless 
holism nourishes from reductionism, having a mutual dependence and complementing each 
other. Following this premise, clinical treatments will shift from reactive and generalized to 
predictive, preventive and personalized medicine [9]. 
Pathologies can be perceived as alterations in any biological network, where an error in the 
system gives rise to a re-wiring event. Therefore, large-scale networks contribute as convenient 
toolkits for the prototypic study of modern Systems Biology throughout quantitative modelling. 
Gene expression provides information on how functionally-related molecules are ubiquitously 
regulated within the cells and stroma that conforms tissues. Having this in mind, one can 
consider that the interaction among the genes expressed in each tissue tend to aggregate in the 
same connected components. These connected components resemble a biological network 
conformation. In addition, only 2% of human diseases result from a single gene defect 
(monogenic). Even on that count, monogenic disorders are rather heterogeneous in nature [10]. 
Although monogenic disorders are caused by a single gene defect, there is a wide phenotypical 
variability in patients with the same causal mutation, and not all the observable disease traits 
can be explained by the gene defect but rather by a combination of several dysregulations in 
gene expression profiles. For that reason, networks can be considered better markers of disease 
than single genes or combinations of them, putting thus the spotlight on overall arrangements 
that can be treated as a single piece using global parameters.  
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There are two elementary objects involved in any network: nodes and edges [11]. Depending on 
the type of biological network represented, nodes and edges will take different aspect and 
meaning. Nevertheless, nodes tend to represent discrete entities -such as genes, proteins or 
diseases-, whereas the edges are the linking elements which symbolize a generic relationship, 
that can be for example an interaction or a transcriptional control.  
b. Biological networks. Types and examination 
 
Prior to analysing the biological networks, it is convenient to understand the main topological 
measurements and parameters of any network formed by nodes and edges (graph theory) [12]. 
Figure 1 collects the main metrics associated with graph topology: 
The degree (K) of a node defines how many edges (connections) a node has to other nodes. 
Likewise, the degree distribution (P(k)) shows how many nodes have a particular degree k 
(Figure 2).  
The clustering coefficient (C) gives an idea of the interconnectivity in the neighbourhood of a 
node. In other words, the cohesiveness of the neighbourhood of a node. The average clustering 
coefficient (c) can be computed as well and recognizes the overall tendency of nodes to form 
clusters. Clustering, or network transitivity, is a fundamental property of any type of network. 
The path length counts the number of edges that separates two particular nodes within the 
graph. Likewise, the shortest path between two nodes finds the minimum number of edges 
(distance) needed to connect those nodes. Another interesting parameter, the betweenness, 
reflects node’s centrality and its “influence” in the network by measuring the number of shortest 
paths that go through the node. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. PICTORIAL GLOSSARY OF COMMON NETWORK METRICS 
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According to the degree distribution pattern, networks can be characterized in three different 
classes of graph models by means of a power-law mathematical correlation (Figure 2) [13]:  
Random Networks: Their nodes share a random number of links. The degree distribution plot is 
a Gaussian curve, where nodes that have a significant deviation from the average are extremely 
rare. 
Scale-free Networks: The majority of networks associated to cells and tissues adopt this 
structure. In them, there is a majority of nodes with very few connections, and a small number 
of nodes that have a high degree. The main graph properties will be determined by the special 
nodes that highly exceeds the average links, also known as hubs. The interactome –showcasing 
protein-protein interactions (PPIs)-, reactome and diseasome and many other complex graphs 
have a scale-free arrangement, where the feasibility to go from almost any node to any part of 
the graph in a minor number of steps confers them the so-called small world characteristic [14]. 
As its name indicates, they are growing networks marked by a preferential attachment where 
the hubs tend to get “richer” in terms of connectivity. 
Hierarchical Network: These networks are a type of scale free networks, represented by a highly 
ordered structure, where the clusters combine in an iterative fashion, creating thus a ruled 
network. Consequently, their average clustering coefficient is markedly high. A few number of 
hubs are in charge of maintaining the conformation and connections between different clusters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2. BARABÁSI-ALBERT MODEL MODIFIED FROM [13] & [15] 
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In order to analyse the data represented in networks, and eventually give a biomolecular 
interpretation of the phenomena under study, these graphs possess, in an inherent fashion, a 
topological structure and connectivity parameters. Upon computational analysis, the network 
showcases evidences of certain patterns and global values, which in turn enables the detection 
and identification of the distinct features of the cellular machinery, providing then solid 
indications underlying complex disease mechanisms [15]. 
c. Introduction to the diseases phenotypes 
 
Genes are segments of DNA molecules located in each chromosome, both autosomal and sexual, 
and they are responsible for the inheritance patterns in living organisms. A gene is a functional 
unit whose expression controls the cell fate, and so the possible outcome of any functional 
tissue. Structure of genes can be seen in Figure 3. The term phenotype refers then to the 
interaction of the genotype –the complete heritable genome- with the environment that gives 
rise to the observable characteristics on each human being [16]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some gene alterations might occur during DNA replication or due to environmental factors, 
giving rise to mutations if they are located in sexual cells that are passed to the offspring [18]. 
 
If the mutation is carried only by one copy of the pair of chromosomes, it is called recessive. On 
the other hand, if it is present in both copies, it is a dominant mutation. The repercussions will 
vary in scope and gravity depending on the alleles (variant forms of a gene) and the function of 
that particular gene carrying the mutation. In addition, if both alleles of a gene are identical, the 
individual is called homozygous. Otherwise, the individual is heterozygous [17].  
 
FIGURE 3. CHROMOSOME TO DNA. UPDATED FIGURE FROM [17] 
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Genodermatoses are inherited genetic skin conditions.  The three genodermatoses studied in 
this project are rare autosomal recessive diseases. Despite of their unalike genetic background 
[19], they have been grouped together because of the similarities they share at the phenotypic 
level (such as skin fragility, inflammation, cancer proneness), which will be studied in detail 
hereafter. 
 
Two out of three are under the epidermolysis bullosa (EB) classification: EB is a rare genetic 
condition, which easily causes fragility and blisters along the skin in response to some minor 
injury or friction. According to its etiology, it is caused by mutations in genes expressing proteins 
related to the adhesion between dermis and epidermis [20].  
 
The recessive dystrophic epidermolysis bullosa (RDEB) is one subtype of the four broad 
categories of EB. With a prevalence of 30.000 individuals in Europe [21], this fatal disorder is the 
most severe, even affecting the mucous membranes of the gastrointestinal (GI) tract and moist 
lining. After a blister heals, it leads to progressive scarring that might include digit fusion and 
even joint abnormalities. A mutation in the COL7A1 gene happens to be the cause of the two 
recessive and one dominant types of DEB. COL7A1 carries the instructions to assemble the 
collagen VII protein, the main constituent of anchoring fibrils, located at the dermal-epidermal 
basement membrane (Figure 4) [22]. 
 
Regarding the prognosis, life expectancy is significantly reduced due to the risk of squamous cell 
carcinoma (SCC) development. Its metastasis incurs an 87% of mortality by age 45 [23]. 
 
Kindler Syndrome (KS) is also a rare disease which belongs to the EB family, the most unusual 
one though, with only about 250 cases reported worldwide [24]. By the same token, skin 
blistering is its major clinical description, driving to fusion of fingers and toes. Moreover, it incurs 
in other skin abnormalities such as poikilodermia, characterized by pigmentation irregularities 
and small dilated blood vessels just under the skin. In addition, it might cause patients to be 
highly sensitive to ultraviolet (UV) light. It is caused by a mutation in the FERMT1 gene, which 
takes over the expression of kindlin-1 protein, a phosphoprotein that has a crucial role in the 
polarity, motility and proliferation of epidermal keratinocytes [25].  
 
In the same fashion, KS also increases the risk of cutaneous squamous cell carcinoma (SCC) 
development.  
 
Cell biological properties of kindlin-1 in basal keratinocytes are ubiquitous, since it is an essential 
player in the cutaneous epithelial stem cell homeostasis (Figure 4). Forming the backbone of the 
basement membrane, collagen VII also appears as an accountable component for signalling 
processes. 
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Xeroderma pigmentosum complementation group C (XPC). Aside from the EB subtypes, the 
other inherited skin condition studied along this project is XPC. With a frequency of 1 in 1 million 
in the United States and Europe, XPC is caused by a defect in the XPC gene, which forms part of 
the DNA repair mechanism. In the skin, its phenotype is characterized by severe sunburns 
present upon individual exposure to sunlight. In other words, patients with XPC have an extreme 
sensitivity to UV rays due to their incapacity to correct mutations [27]. Sunburns then transform 
into freckling in affected young children. Dry skin and changes in skin pigmentation ultimately 
make the name of xeroderma pigmentosum. 
 
It is a quite heterogeneous disease, taking into account that at least eight different forms of XP 
have been found [28]. The mutated genes are involved in the nucleotide excision repair (NER) 
pathway [29] (Figure 5). As a result, DNA is not repaired properly and the accumulated 
abnormalities eventually make the XPC patients prone to malignant melanoma.  
FIGURE 4.  SCHEMATIC ILLUSTRATION OF THE FOUR MAIN ROLES OF KINDLIN-1. A) CELL ADHESION AND INTEGRIN 
SIGNALLING, B) MITOTIC SPINDLES AND CELL SURVIVAL, C) RELEASE OF TGFB AND D) SUPRESSION OF WNT 
SIGNALLING. SOURCE [26] 
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Furthermore, these three genodermatoses lead to chronic irritation and inflammation, which is 
indeed a critical component in tumor progression. Inflammatory cells orchestrate the neoplastic 
environment, where the signalling molecules of the innate immune response combine with 
receptors for survival, proliferation and migration during metastasis [30]. In short, they are all 
cancer-prone. Besides, all these three genodermatoses imply vision impairment [23, 24, 27]. 
 
In spite of their matching related phenotype, the mutated genes of each disease have different 
chromosomal locations and a very low nucleotide base sequence similarity according to the 
National Center for Biotechnology Information (NCBI). Simply put, they seem to have a poor 
correlation at the genomic level.  
 
Therefore, in order to obtain molecular mechanisms that can explain the similarities in the 
phenotype, other levels of data apart from genomics, must be analysed and integrated. 
 
d. Integration of omics data 
 
In order to build a bridge between System Biology and network medicine and, in turn, infer 
causal associations between gene expression and diseases, mathematical and relational models 
need to be introduced [31]. In this manner, the collected and shared data from bioinformatics 
repositories ought to be exploited after its discovering. Consequently, due to the massive 
amount of heterogeneous high-throughput data that NGS technologies can make available into 
these databases, computational systems biology ought to improve omics data integration [32]. 
Omics integration promises to be capable of disclosing hidden biological knowledge, addressing 
thus biomedical problems. Essentially, it combines multiple data types to compensate unreliable 
information in any independent data set and to obtain a further system biology insight into the 
functioning of cells as a whole.  
FIGURE 5. NER PATHWAY DIAGRAM. UPDATED FIGURE FROM [29] 
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There are two main sources for omics data [33]: the so-called knowledge databases, namely 
ontologies, which collect a detailed framework of the majority of mechanisms and functions of 
each individual component in a species, and the clinical data, that corresponds to experimental 
designs and patient sequencing data. The latter tends to have annotated expression values for 
every single sequenced entry. 
To fully characterize the cellular mechanisms and thus the organ functioning (or malfunctioning), 
researchers need a methodology capable of increasing the value of both the previously 
deposited knowledge and the continuous rise of clinical annotated data. The major challenge 
that the omics technologies confront are the redundancy-free information –no futile overlaps 
among shared data- and the efficiency at ruling out the false positives [34]. 
Talking about omics integration means talking about the different projects that have previously 
appeared willing to investigate the complexity of the biological systems. The most relevant 
paradigms are the 1000 Genomes Project [35,36], Encyclopaedia of DNA Elements Project [37], 
Cancer Genome Atlas Project [38] and the Immunological Genome Project [39], among others. 
During the course of these ventures, novel methodologies to analyse and integrate data have 
evolved, providing a wide variety of algorithms for concrete purposes: alignment of markers 
with molecular activities, self-organizing maps, inference of regulatory networks, etc. 
From all the integration approaches carried out, the most prominent algorithm established, able 
to work with multiple variables in a computationally feasible manner, is the meta-dimensional 
analysis [40]. It consists of a simultaneous integration of non-linear interactions with high-
throughput data to get a global picture of a trait. The multivariable prediction model generated 
comes with a particular outcome. This method avoids the common limitations that can present 
the rest of the approaches, such as the multi-staged analysis, which assumes that genetic 
variations are hierarchical. Multi-staged might be very useful by the time of associating in a 
linear manner a change in gene expression with a change in the phenotype (Figure 6). However, 
it has been stated that disease patterns are non-linear and quite interactive in reality, having a 
more complex nature that cannot be fully fitted in a stepwise, linear model such as the multi-
staged analysis. In our work, an approach to omics integration using biological networks will be 
committed, since graph constructions enable to undergo meta-dimensional analysis of omics 
data. 
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All the massive amount of biological data is then grouped on different levels of regulation, 
resultant from each particular omic-technology employed to target the distinct molecular 
entities. The accepted classification of these omics levels is the following (Figure 7):  
Genomics 
Genomics is a catch-all term that collects studies of genes and genomes at the DNA level 
(variants, copy number, regulatory sequences, etc). It is the broadest and most mature of the 
omics disciplines. The retrieved genomic data has made sense to several gene-regulatory 
functions and procured the biogenesis of the species whose genomes have been completely 
sequenced today [42]. Therefore, genome-wide studies have provided evidences and new 
discoveries regarding the evolutionary tree of life.  
Transcriptomics 
Transcriptomics field yields information about RNA transcripts abundance. Since the transcripts 
level determines the gene expression state within the cells, measuring the RNA amount 
accounts for a snapshot about the active and dormant cellular processes that are taking place in 
a cell. Contrary to genomics, it has to deal with quantitative results. First attempts are dated to 
the 1990s and they have reached a point –as Microarray and RNA-Seq technologies flourished- 
where the volume of RNA collected can catch up with the recorded DNA entries [43]. Unlike 
Microarray technology, RNA-Seq is not dependent on any prior genomic knowledge: it examines 
the quantity and sequences of RNA in a sample by means of NGS (for this to occur, RNA 
FIGURE 6.THE GEUVADIS PROJECT. COMBINATION OF MRNA AND MICRORNA SEQUENCED 
DATA TO CHARACTERIZE REGULATORY VARIATION IN HUMAN POPULATIONS. SOURCE [41] 
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fragments are converted into a cDNA library). Essentially, RNA-Seq uses shorts reads of 
messenger RNA (mRNA) where intronic content has been discarded, and then aligned back to a 
reference genome or assembled, providing eventually a comprehensive map view of the whole 
transcriptome [44]. In this way, transcriptomics assists on capturing gene dysregulation 
patterns. It is true that alterations can occur out of the traditional genetic basis for inheritance, 
that is, without mutating the DNA codifying sequence (epigenetic). In this way, post 
transcriptional modifications such as mRNA silencing, orchestrated by microRNAs, will lay on 
this subcategory called epigenomics [45].  
Proteomics 
This discipline quantifies the protein amounts within cells at a certain time point. Coined in 1997, 
the proteome information explains the functions encoded by any gene, throughout the analysis 
of the overall composition, structure and activity of the proteins. On the basis of their mass and 
charge, proteins are characterized by using mass spectrometry strategies [46]. Proteomics data 
can appear in biological networks in the form of physical connections (at the molecular level) 
among proteins, which are called protein-protein interactions (PPIs). 
Metabolomics 
This unique biochemical approach seeks to identify the set of metabolites –any small substance 
involved in metabolism- found within tissues, biofluids and microbiome. It is closely related to 
the phenotype and apparently there exists a crosstalk between epigenetics and metabolomics 
[47]. For that reason, it is an emerging tool able to elicit powerful pathogenesis information. 
Mass spectrometry offers as well a sensitive technique to capture metabolomics data.  
 
Considering this set of layers where the omics data can be batched, either vertical or horizontal 
integrative analysis can be performed [48]. In terms of suitability, each one can offer some 
benefits depending on the ultimate purpose. However, these different layers are not so 
descriptive on their own and molecular mechanisms cannot be fully explained with the 
information from just one. Their complementary interplay hence becomes more meaningful and 
efficient over the bioinformatics advancement. What is more, the published work has 
traditionally been focused on genomics and transcriptomics [49], that is, DNA and RNA 
sequenced molecules, lacking thus substantial meta-data required for the cross-analysis and 
integration along the rest of the layers. Besides, dimensional overfitting –the excessive use of 
the experimental space and the variables allowed in a specific study- is impeding as well the 
proper attainment of omics compendia [50].  
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The omics-driven predictive modelling allows to view as a whole, through integration of the 
biological data, the complex crosstalk among all the molecular entities that are responsible of 
pathways, pathologies and diseases. 
On top of that, the integration over multiple omics layers seems to be a reasonable approach in 
order to develop hypothesis that lead to the determination of molecular causes of disease. 
Nevertheless, as long as the peculiarities of any given experimental setting and the deprivation 
of standards are not tackled, data quality control is a major concern though [52].  
e. A regulatory overview 
 
As aforementioned, transcripts are studied by the transcriptomic field. Their regulation is a 
critical step in the central dogma process (DNA→RNA→Protein), since it determines the gene 
expression into proteins. On this basis, there exists a set of small molecules consisting of ~22 
nucleotides whose performance can disrupt the translation process. These non-coding and 
single-chain molecules are named microRNA (miRNA), and belong to an RNA interference 
pathway which neutralizes mRNA molecules [53], controlling the activity of genes and inhibiting 
thus gene expression in cells.  
These “knockdown” events can be used in loss-of-function studies, so microRNAs are considered 
relevant players in the human interactome. In this way, microRNA & non-coding RNA analysis is 
a valid approach to understand the protein role and abundance in a particular condition. 
The mechanism of action consists in a hybridization where the base pair complementation 
between the microRNA and the target mRNA leads to the degradation of the latter [54] (Figure 
8). However, the complete knowledge regarding its functioning and involvement in physiological 
and pathological processes is still scarce. 
 
 
FIGURE 7. TRANS-OMICS APPROACH. SOURCE [51] 
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FIGURE 8. POST-TRANSCRIPTIONAL GENE SILENCING UNDER MICRORNA ACTION. SOURCE [55] 
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2. HYPOTHESES AND GOALS 
                                                                                                                                                             
Recessive Dystrophic Epidermolysis Bullosa (RDEB), Kindler Syndrome (KS) and Xeroderma 
Pigmentosum type C (XPC) are three phenotypically related genodermatoses. Even though these 
three inherited skin disorders hold a different genomic origin (mutations in COL7A1, FERMT1 
and XPC respectively), some of their intra and extracellular life mechanisms could be somehow 
shared, which would explain eventually their common phenotypic traits.  
By using omics technologies (RNA-Sequencing, microRNA Sequencing and Protein-protein 
interactions), both transcriptomics and epigenomics data from the three genodermatoses can 
be obtained and analysed. The hypothesis underpinned herein is that the construction and 
interpretation of biological networks gives rise to a traceable framework of interactions among 
entities that might serve as a convenient approach for the study of the aforementioned common 
hallmarks (cell-cell adhesion, inflammation processes and cancer proneness).  
This blueprint proposes a novel procedure for narrowing down high-throughput clinical data to 
end up with candidate genes and their regulatory microRNAs which might govern the 
RDEB/KS/XPC transcriptional profile. 
The aim of acquiring a global transcriptional profile for the three genodermatoses is endorsed 
by the idea that a common-injury event causes certain epigenetic changes which in turn lead to 
a stable cancer associated fibroblasts (CAF)-like phenotype [56]. This phenotype would be 
shared by the three diseases, regardless of their different genetic origin. As expected, in this 
paper, the omics profiling revealed a high resemblance among the genodermatoses in contrast 
to healthy individuals. Put another way, under this similar transcriptional signature, it can be 
speculated that a triggering event makes fibroblasts detect adverse cues and forces them to self-
activate and start secreting aberrant extra-cellular matrix (ECM) molecules, driving into a CAF-
like phenotype. Understanding the causal genes that are in charge of the convergent themes 
among genodermatoses is what gives a meaning to this transcriptome and epigenome 
sequencing.   
Upon the construction of the biological networks, and performing system-level observations 
(both topological and functional), the initial RNA entries will be short-listed, leading to candidate 
biomarkers, whose regulation by microRNAs would hopefully serve as a working basis for 
prospective pharmacological research.  
The main goal of this project is to develop hypothesis that can explain, through an integrative 
network approach, the mechanisms that govern the expression of genes and that regulate their 
cellular level (through microRNAs) in three different, but related, genodermatoses. 
To accomplish this, some other goals are approached, such as the validation of the previous 
results from RNA Sequencing, the topological analysis of integrated networks and the biological 
interpretation of the results. 
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3. MATERIALS & METHODS 
a. Data Origin & Statistical Analysis 
The transcriptomic and epigenomic data herein utilized come from a study carried out by 
Chacón-Solano et al. [56], where skin biopsies of four different patient cohorts (a total of 9 RDEB, 
3 KS, 3 XPC patients and 3 healthy individuals) were obtained following the World Medical 
Association Declaration of Helsinki Principles [57]. As a first step, patients were screened for the 
mutation responsible of the disease. Both keratinocytes and fibroblasts from the skin biopsies 
were isolated, cultured and grown until confluency was reached. Next, RNA from fibroblast 
samples was extracted and submitted to RNA-Sequencing analysis in order to obtain short 
sequence reads that were posteriorly aligned and assembled together. This RNA sequencing will 
determine which genes and microRNAs are induced/repressed in each of the aforementioned 
pathologies compared with the healthy volunteers. To discard any sort of bias, artifacts or batch 
effects in the linear model, a principal component analysis (PCA) was carried out: PCA confers 
to all the components independence of one another. The normalized RNA-Seq counts yielded 
22970 transcripts, and sample processing ensured the quality control of the fastq sequences 
using FastQC [58]. Each of these transcripts was subjected to statistical analysis, comparing 
disease vs healthy samples, where different quantitative annotations were obtained: 
LogFC: It measures the logarithm of fold change that exists in a specific variable for two distinct 
samples. In the Chacón-Solano et al. [56] study, it is referred as the gene expression of the 
patients reads when compared to the healthy individuals. In this way, a positive log fold change 
value will mean an overexpression of that specific gene when compared to the controls, and 
underexpression otherwise. 
P-value: The probability, under the null hypothesis, that the differential expression between 
diseased and healthy entries is statistically significant. By scientific convention, the decision 
about the significance of a result is cut off at 0.05.  
FDR: When dealing with large sequenced data, it is important to reduce the likelihood of false 
positives that can be misread. The false discovery rate stands as a corrected p-value when 
conducting multiple comparisons. 
This whole RNA-Seq approach was also employed to sequence and render the microRNA reads 
of each sample.  
Finally, data group comparison upon Venn’s diagram visualization (Venny 2.1.0) [59] gave a 
result of 227 genes and 18 microRNAs that were commonly dysregulated in the three 
genodermatoses.  
Undertaking network construction and analyses is the selected approach to downstream study 
these omics data in the present project. 
A schematic overview of the data origin and previous statistical analysis can be seen in Figure 9. 
Now that all the entries are properly annotated, they have got a statistical meaning, 
representing hence the take-off point for the subsequent testing and plan of action. 
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b. Data Validation 
 
Clinical data requires a reliable validation to ensure findings are not just random findings. 
Trustworthiness and veracity of microRNA sequencing data was assessed in this case. Specially 
in omics data, where the massive amount obtained is hampered by the appearance of possible 
false positives and negatives, due to artifacts for accuracy and precision of the technologies 
employed. 
Skin biopsy 
Isolation & purification of 
primary cultures 
Statistical analysis 
 (PCA & t-test) 
Fibroblast in vitro 
amplification 
RNA & microRNA 
preparation 
Library construction 
Sequencing on NGS 
platform 
Quality control  
Fast QC 
Reads analysis 
Genodermatoses cohort 
 (RDEB, KS, XPC) 
Healthy volunteers  
FIGURE 9. DATA ORIGIN THROUGH RNA-SEQ 
Selection of common dysregulated                      
RNAs and microRNAs (Venn) 
17 
Among the 18 common microRNAs, several candidates were selected for biological validation, 
based on a topological analysis of microRNA networks from a previous study [60] and also their 
biological interest in the diseases. In order to study the biological relevance of these selected 
microRNAs, a bioinformatics analysis was carried out, with the aid of mirPath v.3 [61], a web-
server employing a DIANA TOOLS algorithm. By means of this method, microRNA targets can be 
either predicted (microT-CDS) or empirically matched (TarBase). Following a leave-one-out 
cross-validation strategy, that is, disabling one microRNA at a time to evaluate how the rest of 
entries interact in their own right, and entering four microRNA every time, it is possible to subtly 
track their functioning in different KEGG pathways [62]. KEGG pathways are understood as a 
convenient compilation of databases which gather ubiquitous biological interactions and 
reactions in the form of diagrams. From this analysis, the most interesting (commonly 
dysregulated) miRNAs from a biological point of view were selected for qPCR validation. 
Besides, another identified microRNA has proved to be a relevant signature in what RDEB 
concerns [63]. Although hsa-miR-29 was not among the common dysregulated ones (it was only 
statistically significant in RDEB and KS vs healthy comparisons), it apparently mediates the 
aberrant ECM synthesis through TGF-β1 induction, which at the same time is associated with 
inflammatory processes [63] and was therefore included in the study. 
Proceeding with these microRNAs functional characterization, it was eventually decided to 
validate hsa-miR-10a-5p, hsa-miR-10a-3p, hsa-miR-29c-5p, hsa-miR-29c-3p, hsa-miR-129-5p 
and hsa-miR-195-5p, using RT-qPCR. 
MicroRNA validation by RT-qPCR was carried out at CIEMAT, where fibroblasts samples from the 
RDEB/KS/XPC patients of the previous studies were grown at the cell culture lab. Isolated 
fibroblasts were subjected then to lysis processes by which all the microRNA content was 
released. The same procedure was applied to different healthy samples (different from the ones 
used in the microRNA-Seq) to further sustain the validation process. The extraction kit employed 
was mirVanaTM miRNA Kit (Applied Biosystems/ Ambion, USA), and the concentration of 
microRNA extracted was evaluated by Nanodrop 1000 (Agilent Technologies, USA) as a first 
instance, and then converted into cDNA using a reverse transcription polymerase chain reaction 
machine for their downstream quantification. RNU6 housekeeping microRNAs primers was used 
as control. Afterwards, quantitative PCR was undergone using Taq-Man technology and kit 
(Thermo Fisher thermocycler). Results were obtained in the form of CT, or minimal cycles, so 
they would need eventually a conversion (with algebraic formulas) in the form of logFC, which 
will indeed tell us the differential expression of the microRNAs of interest. Final statistical 
analysis (PRISM 6.0) was configured with Mann-Whitney (non-parametric) test. 
c. Transcriptomics and epigenomics integration. Cytoscape 
 
The maxim of biomedicine network analysis is to 1) begin with a reliable initial list of biological 
omics data, 2) display in a network their interactions across every molecular level and 3) gain 
biological insights from the integration analyses of the network.  
In our case, after the screening, transcriptomics and epigenomics data was firstly obtained and 
validated. From that point, an integration analysis was conducted using Cytoscape [64]: a user-
friendly, open source platform that is considered today as de-facto standard software in the 
bioinformatics state-of-the-art. Its range of possibilities is outstanding, with an architecture that 
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is continuously being upgraded by the scientific community. The core structure, designed at the 
Institute of Systems Biology in Seattle, is fairly compatible and interoperates with other existing 
bioinformatics tools. Cytoscape orchestrates every single step involved in the understanding of 
biomolecular interaction networks (Figure 10): 
 -Integration of biological networks with gene expression profiles and its management. 
 -Navigation and customization of network data displays. 
 -Import and export of all the constructed graphs and annotated tables. 
 -Work alongside biological literature found at biobanks and ontologies. 
 
 
 
 
 
 
 
 
 
 
 
Cytoscape plug-ins obtain the biological information from a number of databases or ontologies. 
The most common one is the Gene Ontology (GO), which classifies all genes and gene functions 
in different hierarchical terms (GO numbers) that define specific functions in three categories 
(Biological Processes, Molecular Functions and Cellular Components). Other databases 
commonly used for enrichment analysis are KEGG and Reactome. Furthermore, it is so 
multitasking that the plug-ins allow for the three steps for network analysis followed in this 
study: 
1) Network generation, in order to generate the integrated omic data network, Cytoscape 
makes use of certain plug-ins that can be subdivided in:  
 Layout and visual properties manipulation. Cytoscape makes use of a wide array of 
instruments and options to tailor any biological network layout. These changes of graph 
appearance allow for a clearer visualization of the pursued molecular entities within the network 
without altering the natural graph structure, that is, nodes and edges distribution. 
 Importation of pairwise connections among classes of entities. Apps like STRING [65], 
which apply quality-controlled interactome data to incorporate, in our case, protein-protein 
interactions (PPIs) along already created graphs. In this way, data from different omics levels 
can be associated on the same network backbone, which entails a crucial step in Integrative 
Bioinformatics. 
FIGURE 10. SCHEMATIC VIEW OF CYTOSCAPE CORE ARCHITECTURE. 
SOURCE [63] 
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2) Topological analysis of molecular elements. In order to analyse the structure of the 
constructed graphs, a global topological analysis was used, which in turn draws the most 
relevant parameters and measures of each network component. Topology certainly highlights 
graph elements, such as nodes and their connections. However, these entities are not 
necessarily biomarkers for our diseases, they might be just related to the graph conformation, 
so their essentiality requires to be downstream studied. 
Cluster and Motif Discoveries. Depending on how nodes and edges are 
arranged/distributed within the graph, different Apps can support the deep examination of 
collective structures of interest within large-scale networks [66] 
  
3) Functional enrichment analyses. Since the ultimate goal has always been to obtain 
phenotype-genotype information regarding pathologies, a powerful tool is required to dissect 
the biological meaning out of the network constructs. To help on this pursuit, the functional 
enrichment stands as an exploratory procedure which uses statistical approaches to identify 
molecular mechanisms that are over-represented within a large set of genes/proteins (in our 
case the common differentially expressed genes). These relevant mechanisms may have an 
association with disease phenotypes. The method employed herein is the singular functional 
enrichment (SEA), which iteratively test the enrichment of each annotated gene by making use 
of an enrichment p-value. This enrichment probability tells the number of genes in a list that hit 
a given biological function as compared to random chance [67]. These genes are considered 
determinant for the specific disease so they can be figured as candidates in terms of the 
biological functions they are involved in. Two interfaces are going to assist within Cytoscape 
environment to undertake the functional enrichment analysis.  
  STRING. In addition to its employment in the detection of protein-protein interactions, 
its Cytoscape plugin can retrieve as well functional enrichments mainly from Gene Ontology 
(GO) [68] and KEGG Pathways terms after setting a confidence cutoff. GO belongs to the so-
called online knowledge databases [33] whose information is subdivided in three categories: 
Biological Processes (BP), Molecular Function (MF) and Cellular Component (CC), all of them 
organized in a nested hierarchical fashion where putative functions are directly related to 
hierarchically successive entities. Yet, this approach is incomplete as not all the existing human 
proteins are annotated in the three GO ontologies. Figure 11 presents an extent of annotation 
of proteins in model species. 
   BINGO. By the same token, BINGO provides an exhaustive perusal of the GO categories 
that are statistically overrepresented in a set of genes present in a graph. By configuring a multi-
parameter kit, the user can obtain the enriched GO annotations and propagate them upwards 
through the GO hierarchy. By these means, every gene annotated to a certain GO category will 
be fitted at once in all the corresponding parental categories [69].  
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Curation pipeline. Due to the non-directed nature of the SEAs, overly a huge number of 
pathways and functions tend to be retrieved in the analyses. Some of them are unrelated or 
redundant, hence certain strategies are employed to refine the obtained results. 
As a method to meet our data with biobanks and ontologies, two different approaches were 
followed: 
- ReVIGO. As its acronym indicates, it serves for reducing and visualizing Gene 
Ontology terms by semantic similarity. For this study, it was fine-tuned using a 
stringent clearance (0.7) and a semantic similarity measure=SimRel. Functional 
enrichment results will be grouped by ReVIGO [71]. 
- ClueGO. Genes of interest from enriched functions will be downstream studied in 
here as candidates for explaining the phenotypic correlations among the three 
genodermatoses. ClueGO comprises one of the most robust Cytoscape plug-ins, 
where functionally organized term networks are elaborated using GO, Reactome 
and KEGG assistance [72]. Since six microRNAs has been experimentally validated at 
the lab, they will be used as a way to reinforce this venture as well. 
 
A detailed flowchart of the tools used, the workflow and the data interpretation are shown in 
Figure 12. In short, microRNA-omics data was imported into miRNet [73], generating a 
microRNA-RNA interactions table. After nomenclature conversion (miRCarta [74]), interactions 
were loaded into Cytoscape for networks construction, adding the protein-protein interactions 
(PPIs) within the network. Topological and enrichment analyses were then carried out, and a 
biological interpretation is subsequently performed. 
 
 
 
 
 
 
FIGURE 11. EXTENT OF ANNOTATION OF PROTEINS IN MODEL SPECIES. PIE CHARTS SHOWCASE YET A SUBSTANTIAL 
FRACTION OF UNANNOTATED PROTEINS, SINCE NOT ALL THE DATABASES IN HUMANS ARE COMPLETE. SOURCE [70] 
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FIGURE 12. DETAILED INTEGRATION FLOWCHART 
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4. RESULTS 
a. Validation of microRNAs 
                                                                                                                                                                      
The first stage consisted in selecting and validating a small set of dysregulated microRNAs by RT-
qPCR from a pool of 18 commonly dysregulated among the three genodermatoses, which was 
mainly performed assisted by miRPath [61]. MiR-10a and miR-10b were excluded of the in silico 
mirPath algorithm because miR-10 has already been confirmed in a wide array of species and its 
precursor family is highlighted prominently in the literature due to their association with 
numerous cancers [75] and notable protein synthesis, so there was no doubt its validation was 
mandatory. Same happened, as mentioned before, with miR-29c [63]. 
In this way, after running the online software, microRNAs with few hits and biological impact 
were discarded for validation. MiRPath interface view can be observed in Figure 13, where 
microRNAs were subjected to leave-one-out strategy. Heatmaps show the arbitrary log (p-value) 
for each analyzed microRNAs across different functions and pathways. 
The first leave-one-out analysis (Heatmap 1) stated that, either leaving the miR-195-5p or the 
miR-129-5p out shortened the pathways list and impact, indicating thus their prominent 
involvement in the mechanisms of interest. Moreover, the miRPath web-server pointed that 
these particular microRNAs are involved (as the top-ranking list indicates) in the “Adherens 
junctions”, “TGF-β signaling” or “Melanoma” functions, among others. This is strengthened by 
the fact that they have proved to empirically regulate 1422 and 545 genes, respectively. 
The second analysis (Heatmap 2) followed the same procedures, this time with the 3p versions 
of miR-195 and miR-129. In spite of the highly significant correlation of miR-129-2-3p to “ECM-
receptor interactions”, its presence in other pathways of interest was slight. 
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After studying the impact of all 18 microRNAs, miR-195-5p, miR-10a-3p, miR-10a-5p, miR-29c-
5p, miR-29c-3p and miR-129-5p were finally validated by RT-qPCR at CIEMAT, following the 
protocol described in Materials & Methods. The final statistical analysis displayed the results 
shown in Figure 14. Red arrows represent the expression status of each microRNA obtained in 
the previous RNA-Seq analysis (namely, upregulation or downregulation). 
 
All the qPCR analyses (Figure 14) rendered a resembling tendency on microRNAs expression 
when compared to results previously obtained in RNA-Seq (with the only exception of miR-195-
5p in Kindler Syndrome), thus validating these microRNAs for the subsequent data analysis. 
 
FIGURE 13. HEATMAPS AND TABLE ANALYSIS OUTPUTS FROM THE MIRPATH INTERFACE 
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FIGURE 14. COLUMN CHARTS WITH ERROR BARS FOR THE SIX VALIDATED MICRORNAS. “*” MEANS P-VALUE < 
0.05 AND “**” MEANS P-VALUE<0.01 (N=3). ARROW IN RED SHOWS THE EXPRESSION TREND OBTAINED FROM 
RNA-SEQ ANALYSIS 
 
b. Network construction 
 
Once validated the RNA-Seq and microRNA-Seq data, the next stage consisted in constructing 
the regulatory networks for each disease. In the following lines, the term “genes” is going to be 
used for convenience when referring to mRNAs or transcripts. 
To build each specific network, links between the differentially expressed microRNAs from the 
RNA-Seq study and all their possible targets were established. This was done using miRNet [73], 
an online platform where the 27 differentially expressed microRNAs from the RDEB vs. healthy 
comparison, the 99 from KS vs. healthy and the 148 from XPC vs. healthy were independently 
uploaded as input files. These numbers came from selecting solely the entries corresponding to 
a FDR lower than 0.05 (Annex). In other words, in study [60], a list of 27/99/148 microRNAs were 
found to be differentially expressed in RDEB, KS and XPC respectively. This analysis of 
dysregulation was accomplished taking healthy controls as reference. After choosing the 
pertinent parameters to run the program (Organism=Homo sapiens, ID Type=miRBase ID and 
Target Type=Genes), a microRNA-mRNA interaction table is rendered consisting of meaningful 
columns regarding tissue specificity, validation method (both predictive and empirical) and links 
to literature, among others. The legitimacy of the predicted interactions is guaranteed by the 
miRanda confident scores. The number of detected microRNA target genes for each disease is 
shown in Table 1. 
In spite of miRNet’s capability to downstream display the interactions table as graphs, miRNet 
usage was no longer continued here since the author’s purpose was to carry these tables to the 
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Cytoscape domain [64], as this tool enables a much more thorough study of complex networks 
by integrating expression data profiles (mRNAs) and protein-protein interaction networks. In 
this way, three tables were initially imported to Cytoscape, containing the 27 microRNAs and 
their 3781 targeted genes for RDEB, the 99 microRNAs and their 7532 genes for KS and the 148 
microRNAs and their 8973 targeted genes for XPC, in compliance with miRNet results. To upload 
the microRNAs in Cytoscape, the identifier had to be changed for compatibility reasons. Hence, 
the microRNA identifier was converted into relative IDs (MIMAT) using miRCarta [74]. The next 
step was to import the logFC corresponding to both microRNAs and genes (again, filtering out 
at FDR=0.05), from the [60] study. Once that the expression data was imported, only a certain 
number of the genes targeted by miRNet have got a value for the logFC. This is due to the fact 
that obviously not all the predicted nor validated interactions between microRNAs and genes 
retrieved by miRNet are actually appearing in the [60] study, since we are only accounting for 
those genes being differentially expressed when compared to controls (healthy individuals). In 
this sense, biologically non-relevant genes were excluded from the network, ending up then 
with the desired bipartite networks where nodes correspond both to microRNAs and genes. The 
number of microRNAs, edges and differentially expressed (targeted) genes that arrange each 
network can be seen in Table 1. These nodes are consequently attributed with logFC values and 
information about the types of regulatory interactions among them. 
TABLE 1. NUMBER OF DE NODES FOR EACH GENODERMATOSES NETWORK AND THEIR CONNECTING EDGES 
 
As depicted in the above table, a commonly shared network was also constructed with the 18 
microRNAs common to RDEB, KS and XPC. This simple check showcases that our initial 
hypothesis appears to be working satisfactorily, since 36 out of the 227 DE genes from the [60] 
study are actually being targeted by the shared differentially expressed microRNAs and, as 
proved further down in this section, they have reasons to be highlighted from a topological and 
functional point of view. 
Apart from that, the “Common Network” is going to serve as a control for our analyses with the 
RDEB/KS/XPC networks, as its structure is indeed a subgraph of the later. 
Once genes appearing in the [60] study are correctly matched to their regulatory microRNAs, 
protein-protein interations (PPIs) were incorporated into our networks (from the interactome). 
PPIs can be understood as physical contacts of high specificity that genes will have once they are 
translated into proteins. Therefore, a sound approach will be to investigate both the predicted 
and already experimental PPIs using STRING database [65], a functional protein association 
consortium. For integration purposes, there already exists a plugin within Cytoscape able to 
make use of STRING. In this manner, gene lists were uploaded as input files, confidence cutoff 
was set at 0.80 (a very stringent value to decrease the fraction of false positives) and the 
maximum number of proteins was left as default. The number of PPIs and interacting genes can 
be seen in Table 2. 
 microRNAs miRNet Genes DE targeted 
Genes 
Edges 
RDEB 27 3781 152 229 
KS 99 7532 135 290 
XPC 148 8973 419 1210 
Shared 18 3277 36 (out of 227) 47 
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TABLE 2. NUMBER OF PPIS PRESENT ON EACH DISEASE GRAPH 
 Genes Interacting Genes Number of PPI 
RDEB 152 42 (28%) 44 
KS 135 33 (24%) 35 
XPC 419 149 (36%) 307 
Shared 36 18 (50%) 34 
 
According to the above STRING outputs based on the Interactome content, a significant amount 
of the targeted genes (24-36%) also experiences other molecular associations among their 
translated protein chains apart from regulation by microRNAs. These PPIs secure the fact that a 
portion of the DE proteins from RDEB, KS and XPC in truth act conjointly in some cellular 
mechanisms. Moreover, Shared Network accounts for a 50% of gene associations by reason of 
topological and functional relations among them. 
The identified PPIs are therefore integrated in the microRNAs → genes networks. At this point, 
a successful integration of epigenomics (microRNAs), transcriptomics (RNAs) and proteomics 
(PPIs) has been committed. For simplicity, from now on, these resulting networks will be called 
“Merged Networks”, and are shown in Figure 15 for each disease.  
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FIGURE 15. MERGED NETWORKS FOR A) RDEB, B) KS AND C) XPC. NODE FILL COLOR 
CORRESPONDS TO A CONTINUOUS MAPPING WHERE RED MEANS UP-REGULATION WHILE BLUE 
MEANS DOWN-REGULATION (LOGFC). PURPLE EDGES DENOTE MICRORNA → RNA INTERACTIONS,
WHILE GREEN DOT LINES ARE PPIS BETWEEN GENES 
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c. RDEB, KS and XPC graphs under topological study 
 
Cytoscape hosts a widget for the topological analysis of networks (NetworkAnalyzer), providing 
information about clusters, hubs, minimal paths or degree distribution. This widget is applied to 
the analysis of each Merged Network. A new window appears with diverse outputs regarding 
graph statistics. It is important to comment that PPI interactions are not directed, whereas 
microRNA→ genes are directed. The bipartite graph can therefore be considered one way or 
another. The topological analysis was done in both directed and undirected ways but since the 
results were very similar, from now on and for simplicity, the networks are considered non-
directional. As said, all three bipartite graphs rendered scale-free distribution results, and the 
microRNAs →genes directionality does not affect to the overall topological computation (Figure 
24). The most interesting topological parameters for each Merged Network can be seen in Table 
3. 
The RDEB Merged Network (Table 3) only presents one connected component, also known as 
clique: every node is somehow connected to every other node; there are no isolated elements. 
Conversely, KS and XPC present a little number of isolated microRNAs: they do not regulate any 
of the differentially expressed genes at all.  
TABLE 3. SOME OF THE GLOBAL TOPOLOGICAL MEASURES FOR EACH GRAPH 
 RDEB KS XPC 
Node Degree 
Distribution 
Scale-free Scale-free Scale-free 
Clustering 
Coefficient 
0.024 0.014 0.053 
Isolated nodes 0 24 9 
Characteristic path 
length 
4.024 4.395 3.863 
Avg. no. of 
neighbours 
3.198 2.778 5.332 
Density 0.019 0.012 0.009 
 
 
A power-law line can be fitted to the degree distribution charts. It adopts the shape 
corresponding to a scale-free distribution: a small number of nodes (microRNAs or genes) are 
going to be highly connected (hubs), being responsible in turn of the network outcome. Due to 
the inherent architecture of our networks, microRNAs are mostly going to act as the hubs, having 
especially high degrees. Their role is to regulate the transcripts outcome. On the other hand, 
some interesting genes might also behave as hubs (if they are regulated by many microRNAs 
and hold protein-protein interactions with many other genes). Its disposition may help to 
identify active hotspots within the network which in turn could serve as potential biomarkers 
for the genodermatoses under study.  
The values obtained for the clustering coefficients (Table 3), were as expected for a scale-free 
network: The XPC network presents the higher clustering coefficient, since a core-cluster is 
embedded within its giant component formed by over 400 nodes. That is the reason why XPC 
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global clustering coefficient is the biggest one. This can be explained due to the higher number 
of genes and microRNAs that were dysregulated in XPC, maybe as a result of its mutational 
nature (inability to repair damaged DNA leads to even more mutations). 
In respect of the characteristic path length, every graph showcases a value typical of small-world 
networks: roughly 4 steps have to be taken in order to reach any point of the network, which is 
quite short indeed. There is a short distance between any pair of nodes. Hubs obviously govern 
this property, acting as end-to-end bridges. This is a classic result in biomolecular networks, 
manifesting that small failures or dysregulations in one of its nodes can rapidly diffuse and in a 
short number of steps, transmitting thus to other different parts of the network. 
The average number of neighbours is fairly related to the clustering coefficient values: the larger 
the number of neighbours, the greater the clustering. However, there is a tendency in our 
networks by which nodes do not extensively share neighbours with others (that is, shared 
network distribution decays exponentially). This can be explained due to the bipartite nature of 
the networks: microRNAs regulate a high number of genes, but these genes in turn are not 
extensively associated with more entities. Of course, there are exceptions (genes with PPIs and 
genes co-regulated by more than one microRNAs), which actually entail important topological 
information, and they will be likely acting as hubs.   
Density is understood as the portion of all potential connections that are real connections. In 
this manner, RDEB network showcases the greater density value, supporting thus its strong 
connectivity: from all the possible interactions that can arise from the nodes, the 1.9% are 
established indeed. It is large enough so it cannot go unnoticed on downstream analysis. 
As a convenient way to locate hubs and identify relevant topological properties of each 
individual node, the topological parameters can be mapped to the network view. In our case, 
degree was mapped as the node size and the clustering coefficient as the node color. By using 
this configuration, an individual examination of each network’s most interesting components 
can be undergone (Figures 16 to 24). 
On the microRNAs side, as expected, they mostly stand as distinctive big nodes with a reddish 
color. This means that, they have a large degree value due to their targeted gene regulation and 
that their clustering coefficient tends to be low: their neighbours (RNAs) does not share many 
other edges with other nodes. These genes belong thus to the periphery (leafs in the three 
structure of the network). This consolidates the assumption that the most relevant hubs will 
have reversely acquired centrality properties within the network.  
RDEB Merged Network 
Among the most connected microRNAs (hubs), it is important to highlight the MIMAT0000242 
(hsa-miR-129-5p, Degree=29), MIMAT0000461 (hsa-miR-195-5p, Degree=28) and 
MIMAT0000253 (hsa-miR-10a-5p, Degree=14). Moreover, they are all traversed by a high 
number of shortest paths (Av. Shortest paths=2.95, 3.03 and 3.43 respectively) accounting thus 
for a high betweenness centrality (0.287, 0.189 and 0.088 respectively). 
As can be seen in Figure 16, a cluster in the Merged Network, the gene with the highest 
betweenness centrality is TIAM1 (0.121), which is linked to 8 elements in total: MIMAT0000253, 
MIMAT0000254 (hsa-miR-10b-5p), EPHA4, LYN, EFNA5, MIMAT0003283, RRAS2 and 
MIMAT0003298. That is, four different microRNAs have showed to dysregulate the translation 
of the TIAM1 mRNA into protein and, on top of that, it somehow experiences physical 
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associations with four DE genes. It is closely followed by TFAP2A, presenting 7 different edges 
that link to: MIMAT0004555, ESR1, MIMAT0000461 (has-miR-195-5p), BCL2, MIMAT0002820, 
MIMAT0003298, MIMAT00045555 and KIT. This time, 5 different microRNAs silence the same 
gene which is in turn associated with three more proteins.  
 
 
 
 
 
 
 
 
 
 
Having a look to the clustering coefficient, ITGA8 has got by far the largest value (0.67). It is easily 
located in the network due to its bluish mapping (Figure 17). ITGA8 possess a strategic location 
in which it is connected to FN1, ITGB8 and MIMAT0003283. ITGB8 in addition exhibits PPIs with 
FN1, which is also regulated by MIMAT0003283.  
 
 
 
 
 
 
 
 
KS Merged Network 
The topological mapping immediately displays a more homogeneous graph where the 
microRNAs do not regulate so many genes and the peripheral nodes are particularly small in size 
compared to the RDEB network. In fact, the most connected microRNAs are MIMAT0000424, 
MIMAT0000252, MIMAT0000242 (hsa-miR-129-5p), MIMAT0000461 (hsa-miR-195-5p) and 
MIMAT0003283 (Degrees=16 and 14 for the first two and 13 for the last three). Moreover, their 
neighbours tend to share edges with other elements in the graph (either genes or microRNAs), 
showcasing then the large centrality of these 6 microRNAs: they are greatly traversed by a high 
number of nodes. 
FIGURE 16. TIAM1 & TFAP2A CLUSTERS 
FIGURE 17. ITGA8 CLUSTER 
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BTG2 is postulated as one of the most relevant genes herein (Figure 18). With a degree of 11 
and an average shortest path length of 3.29, it is impressively regulated by 11 different 
microRNAs among whom one should point out MIMAT0000252, MIMAT0000461 (hsa-miR-195-
5p) and MIMAT0000681 (hsa-miR-29c-3p).  
 
 
 
 
 
 
 
 
 
 
It is important to mention as well HOXA10 (Figure 19). With a degree of 8 and an average 
shortest path length of 3.27, it resembles to BTG2’s structure. Among the 13 different 
microRNAs, the most significant are MIMAT000424 and MIMAT0000461 (hsa-miR-195-5p). No 
PPIs have been recognized either for HOXA10. 
 
 
 
 
 
 
 
 
 
Regarding the clustering coefficients, there are two community structures that can be easily 
perceived at a glance by their non-reddish mapping (Figure 20): The first one is represented by 
SERPINE1, IGF2 and FN1, which seem to work together. SERPINE1 is regulated by two interesting 
microRNAs that are MIMAT0000243 and MIMAT0000437. Moreover, FN1 interacts with ITGB1 
and ESR1. The other interesting clustered structure is formed by the genes SOCS2, RNF182, 
HERC3 and MIB2. SOCS2 also connects to KIT and MIMAT00004333, which regulates HOXA10. 
 
 
FIGURE 18. BTG2 AND ITS NEIGHBORS 
FIGURE 19. HOXA10 AND ITS NEIGHBORS 
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XPC Merged Network 
A giant core-cluster can be appreciated the moment we map the topological parameters, with 
small-size genes in the periphery as well. Since it stands as the largest-scale graph (568 nodes 
and 1517 edges, from which 307 are PPIs), its topological analysis is not very intuitive. 
Regarding the degree, MIMAT0000646, MIMAT000075 and MIMAT0000242 (hsa-miR-129-5p) 
are pinpointed as the most relevant (Degree= 55, 42 and 37 respectively). However, a bunch of 
other microRNAs also have important degree values (in the order of three and two dozens). For 
instance, MIMAT0000461 (hsa-miR-195-5p) has got 32 edges and adopts a very interesting 
location inside the giant core-cluster where it shows a highly-ranked betweenness centrality 
(0.037).  
Among the genes with larger degree values, STAT1 and HERC5 (Figure 21) look to have an 
important influence in the core-cluster too (Degree= 21 and 19 respectively). On top of that, 
STAT1 is also regulated by the major microRNA of this graph: MIMAT0000646. Looking deeply, 
in fact, a PPI is held between STAT1 and HERC5, which conjointly give rise to an impressive 
cluster where every node is a gene. Simply put, a highly interconnected PPIs cluster is found 
embedded in the XPC Merged Network, where two quite relevant genes (STAT1 and HERC5) 
appear to have a notorious role. The bluish mapping of these cluster nodes confirms the 
aforementioned. 
 
 
 
 
 
 
 
 
FIGURE 20. SUBGRAPHS WITH HIGHER CLUSTERING COEFFICIENTS 
FIGURE 21. HERC5 CLUSTER 
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These two genes are followed in the degree ranking by ITGB1 (Figure 22), with 16 edges that 
connects to a wide array of nodes: 6 microRNAs of different node-size regulate ITGB1 and 10 
genes with significant clustering coefficients (pale node-color), being: ITGB4, TGM2, L1CAM, 
FN1, KDR, ITGB3, FYN, TGFB1, FBN1 and ITGB8. Several of them have been previously 
commented and will be discussed later on.  
 
 
 
 
 
 
 
 
 
 
 
 
Some of the top-ranked gene nodes with higher betweenness centrality values are included in 
the previous clusters. Others like ESR1, TFAP2A and BTG2 (Figure 23) deserve as well being 
mentioned (betweenness centrality= 0.014, 0.008 and 0.014 and degree=12,10,11 respectively). 
Into the bargain, TFAP2A presents PPI with ESR1, which is in turn connected to FN1 and 
regulated (among 6 others) by MIMAT0000242 (hsa-miR-129-5p, degree=37). 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 22. ITGB1 CLUSTER 
FIGURE 23. ESR1, TFAP2A AND FN1 CLUSTERS 
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d. Functional enrichment analysis 
 
Functional enrichment analysis was performed using two different plugins from Cytoscape: 
BiNGO and STRING. By loading the DE gene lists (those genes that are differentially expressed 
and are regulated by the microRNAs), a table is rendered where the DE genes are grouped on 
different enriched GO and KEGG functional categories. Basically, if a significant number of genes 
are identified to presumably mediate in any of the biological categories recorded in the 
ontologies, it is marked then in the correspondent enriched function. By these means, every DE 
gene is computationally tested, retrieving enriched functions in which they are involved (Figure 
25). In the STRING plug-in, an overall automatically computed PPI enrichment score will tell 
whether the network PPIs are more significant among themselves than a pure random set of 
PPIs of similar size picked from the genome. In other words, if PPI p-value enrichment is lower 
than 0.05, it can be stated that the enriched genes are at least partially biologically connected, 
as a group.  
In addition, and for visual purposes, charts by colour can be plotted along the PPIs networks, 
representing the participation of each gene in the five most relevant enriched functions 
(according to the adjusted p-value). However, these most relevant enriched functions might 
correspond to generalist processes or pathways, not saying too much about specific molecular 
mechanisms.  
FIGURE 24. DEGREE AND CLUSTERING COEFFICIENT MAPPED FOR EACH NODE ON THE GENODERMATOSES 
GRAPHS A) RDEB, B) KS AND C) XPC 
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The other plug-in, BINGO generates hierarchical models where the plotted elements are 
naturally enriched functions. Setting up a proper Hierarchical Layout after its creation, the graph 
adopts a directed tree fashion, also known as dendogram. This graph is nothing but an enriched 
subnetwork out of all the GO terms that have been recorded over the years in the Gene Ontology 
Consortium [68]. Due to its inherent structure, they exhibit manifest family relations, where the 
higher-level “descendants” come from certain “ancestors” and these branches, in turn, from a 
root node.  
In this way, these hierarchical graphs are constituted by nodes (representing each ontology 
term) whose parameters are computed by BINGO, yielding 1) an adjusted p-value which 
corresponds to the gradual node fill color scale (the lower the p-value, the darker the fill color) 
and 2) a “node size mapping” provided by the amount of functional overrepresented genes 
integrated in every enriched function. 
Some nodes act as interconnectors: they are not enriched nor contain any functional genes at 
all, but are used as a convenient bridge between enriched functions that are not directly linked 
by themselves. These interconnectors are depicted as white (or empty) nodes and, by algorithm 
default, sometimes they appear as end-nodes as well. 
The Gene Ontology is composed of three different functional categories 1) Biological Process 
(BP), 2) Molecular Function (MF) and 3) Cellular Component (CC), and therefore three 
hierarchical graphs are retrieved for each genodermatoses DE gene list, thus ending up 
eventually with 9 different BiNGO enriched networks. As our purpose is to study the common 
FIGURE 25. STRING PPIS AND FUNCTIONAL ENRICHMENT ANALYSIS NETWORKS FOR THE DE GENES 
CORRESPONDING TO A) RDEB, B) KS AND C) XPC.  
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resemblances among the functional enrichment analyses for the three diseases and in order to 
simplify the analysis, Cytoscape was used to generate networks intersections between the three 
diseases for each functional category. In this manner, three final intersected networks are 
obtained where the enriched elements are jointly shared by RDEB, KS and XPC (Figure 26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
The leafs, or end-nodes, are going to be mainly the enriched functions of interest, since they 
retain statistically significant biological diversity. This arborescence can be studied to determine 
the disease molecular development that caused the shared phenotype signature by the three 
genodermatoses. 
The enriched functions both from STRING (KEGG database) and BINGO (Gene Ontology) are 
collected all together in a table according to the enrichment p-values they rendered in both 
executions. Some of these enriched functions were to appear in both analyses, while other 
appeared just in one. An insightful scheme is depicted in Figure 27. By performing both single 
enrichment analyses (SEAs), we are increasing the likelihood to cover the majority of the 
enriched elements. 
 
 
 
 
 
 
 
 
Singular enrichment 
analysis (SEA) 
Input gene list 
from RDEB, KS & 
XPC networks 
Input gene list 
from RDEB, KS & 
XPC networks 
Enrichment for 
RDEB 
Enrichment 
for KS 
Enrichment 
for XPC 
Biological Processes  
Molecular Functions 
 
Cellular Components 
 
Biological Processes  
Molecular Functions 
 
Cellular Components 
 
Biological Processes  
Molecular Functions 
 
Cellular Components 
 
Common enriched BPs 
Common enriched MFs 
Common enriched CCs 
Whole enrichment for RDEB  
Whole enrichment for KS  
Whole enrichment for XPC 
GO 
GO, KEGG  
& InterPro 
FIGURE 26. BINGO FUNCTIONAL ENRICHMENT NETWORKS FOR THE INTERSECTION OF A) BP, B) MF AND C) CC. NODE 
SIZE IS MAPPED WITH THE NUMBER OF GENES ENCOMPASSED, AND NODE COLOR IS MAPPED WITH THE ENRICHMENT P-
VALUE 
FIGURE 27. SEAS APPROACHES. IT IS IMPORTANT TO NOTE THAT STRING DOES NOT RETRIEVE NETWORKS WITH ENRICHED 
FUNCTIONS, ONLY PPIS GRAPHS 
40 
e. Grouping and operating with the enriched functions. 
ReVIGO & ClueGO 
 
Merging parallel SEA datasets is a convenient and necessary point to further explore the 
enriched functions. The generated data was compiled in order to make it properly accessible for 
its succeeding analysis. By these means, system-level intepretations can be performed as a 
conclusion. 
A priori one might argue that BiNGO SEAs are more reliable since they already include an 
intersection of the enriched functions shared by the three diseases. However, STRING SEAs 
potentially enclose important evidences too as they include a broadly used database (KEGG) and 
would therefore stand for a wider functional coverage.  
Since 804 out of the 831 functions gathered from all the SEA datasets were detected at the GO 
server, the grouping was carried out using ReVIGO [71], a bioinformatics tool that clusters gene 
ontology terms according to similarities in their functions. The rest of the entries correspond to 
strikes at either KEGG or InterPro (protein domain) databases, and as the number was not too 
large they did not necessarily need to be grouped. 
It is important to note that each single enriched function could have been rendered for one, two 
or even for the three diseases. In other words, not all the enriched functions have the same 
distribution across RDEB, KS and XPC. For instance, “sequence-specific DNA binding”, (which 
corresponds to the GO term GO:0043565) is an enriched function only for KS and XPC, while 
“cellular response to lipid” (or GO:0071396) is enriched only in RDEB and XPC. Moreover, as two 
analogous SEA approaches were followed (BINGO & STRING), some enriched functions even 
have two parallel (non-identical) p-values resulting from both algorithms. 
By the time of grouping the enriched functions by their GO semantic similarity using ReVIGO, 
those entries that had got more than one p-value (either due to their manifestation in at least 
two genodermatoses or because they were part of both STRING & BiNGO results) are considered 
only once at the ReVIGO input interface and have been assigned with the highest p-value found 
for them in the compiled dataset. For instance, “central nervous system development”, or 
GO:0007417, has gotten an enrichment p-value of 7.60E-03 in BINGO for RDEB, while 4.57E-04, 
2.50E-04 and 7.55E-06 in STRING for RDEB, KS and XPC respectively. This GO term accounts then 
for 4 entries with the same description name but with different false discovery rates. Therefore, 
we entered 7.60E-03 (the highest one, securing the statistical certainty) as the input for 
GO:00007417. Yet, the process is completely consistent since ReVIGO only uses p-values to 
guide the grouping selection, if possible. They do no mediate in the choice of the clusters’ 
representatives. Other than that, p-values have no further use in biological interpretation of 
results, since all the enriched functions are statistically significant (p<0.05) due to the nature of 
the functional enrichment analysis (only considers functions that are statistically significant 
enriched in the DE list of genes). 
After setting up the input data, i.e, every GO Term ID and the enrichment p-value, they can be 
loaded in ReVIGO (Figure 28), where the allowed semantic similarity was 0.7 (Figure 28). In this 
way, 521 enriched GO terms were uploaded (283 repeated terms were excluded).  
 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The output of ReVIGO provided several clusters of functions. The retrieved table (Figure 29) 
includes columns regarding frequency (the greater the frequency, the more general the GO term 
is), log10 p-value, uniqueness (to check for atypical values, also known as outliers) and 
dispensability (a measure to group GO terms within the clusters). 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 28. REVIGO INPUT INTERFACE 
FIGURE 29. SNAPSHOT OF THE GROUPED GO TERMS 
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Upon visualizing the results in Figure 30, it is appropriate to highlight that the Molecular Function 
category (MF) displays a set of 27 enriched elements, where the majority relates to binding 
processes and functions, whether for intra or extracellular environments. 
ReVIGO also displays interactive graphs to examine the clusters formed (Figure 31).  
As an example, the interactive graph for the Cellular Components (CC) from ReVIGO was opened 
with Cytoscape, and includes three well-established clusters where every single enriched 
function (now represented like nodes) has to do with membrane and binding structures. First 
cluster contains tight entities of the plasma membrane, the nodes of the second one bears 
relation with the extracellular space, while the third cluster is about cell-cell junctions. 
 
 
 
 
 
 
 
 
 
 
FIGURE 30. ENRICHED MF TREEMAP 
FIGURE 31. CELLULAR COMPONENTS (CC) CLUSTERS 
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This ReVIGO validation provides a confirmation that the candidate BP, CC and MF of interest for 
our study are, as expected, sufficiently represented in the overall picture: “cell-cell adhesion”, 
“extracellular matrix structures”, “regulation of inflammation processes”, “development”, 
“chemotaxis” and “cell cycle” are, among others, the most recurrent enriched functions in the 
three genodermatoses, which makes sense according to the phenotype of the diseases.  
However, at this stage, the results from ReVIGO only provide unrefined aggrupation of functions, 
so a more sophisticated approach is used hereafter with a different Cytoscape tool, named 
ClueGO. Up to now, a systemic analysis has taken place where all the enriched functions have 
contributed equally (yet depending on their enrichment p-value). ReVIGO grouping allowed to 
keep track of the most relevant enriched hits. The grouped dataset was curated afterwards, to 
only consider those enriched functions somehow conjointly shared by all RDEB, KS and XPC 
(Figure 32). As can be seen in this figure, some functions, processes or pathways can be 
commonly dysregulated among the three diseases, although the individual DE genes that trigger 
the dysregulation may be different. Manual curation allows us to specifically select those 
enriched functions that are indeed shared by RDEB, KS and XPC. With that in mind, we can 
perform another downstream analysis, i.e. ClueGO, in step with ReVIGO outcomes.  
ClueGO is another Cytoscape plugin where gene lists can also be systemically analysed, though 
encompassing more options and features. Multiple annotation and ontology resources cover 
the running of the program, which allows to display the results in graph form too. Basically, 
genes are mapped on the selected ontologies and if the predefined criteria are met, the 
algorithm sets the interrelationships among genes. 
 
 
 
FIGURE 32. AN ILLUSTRATIVE EXAMPLE IS PROPOSED TO EVIDENCE THE TABLE CONSTRUCTION BASED ON 
ENRICHMENT P-VALUES, TAKING SIMULTANEOUSLY THE THREE GENE LISTS AS INPUTS 
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To do so, the three gene lists (RDEB, KS and XPC) for each enriched function were imported in 
the ClueGO input panel. The database employed in this approach was REACTOME, for both 
Reactions and Pathways. Overall, “REACTOME Pathways” gathers 2227 recognized pathways 
and 10629 available unique genes and “REACTOME Reactions”, for its part, 11635 terms with 
10894 genes. In a general picture, REACTOME is the most compatible ontology with ClueGO, so 
its running fits properly with the results rendered by both STRING & BiNGO. In Figure 33, the 
ClueGO input panel is showcased, where the RDEB/KS/XPC DE genes for the “epithelium 
development” enriched function has been introduced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
One by one, all the functions that have been found to be enriched with DE genes from the three 
genodermatoses (in RDEB/KS/XPC) are subjected to a final functional analysis with REACTOME. 
A total of 39 functions from BiNGO enrichment study fulfilled the aforementioned requisite, 
whereas 35 enriched functions from STRING met the needs. A thorough scrutiny of the results 
led to the construction of a worksheet (Table 4 for BiNGO and Table 5 for STRING) where all the 
retrieved elements by REACTOME were compiled, for every enriched function. In these tables, 
columns exhibit recurrent hits retrieved by ClueGO and marked for each enriched function. The 
total number of recurrent hits is shown at the last column and row of each worksheet. These 
hits might explain some of the hallmarks from the genodermatoses phenotype. 
 
 
 
 
 
 
FIGURE 33. INPUT PANEL FOR CLUEGO. DE GENES FROM RDEB/KS/XPC HAVE BEEN IMPORTED IN THE UPPER-
LEFT CORNER 
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TABLE 4. WORKSHEET FOR BINGO EFS 
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TABLE 5. WORKSHEET FOR STRING EFS 
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Thanks to the traceability of the enrichment analysis, the dysregulation distribution for each 
enriched function was surveyed (Figure 34). Basically, gene dysregulation was assessed within 
each enriched function: according to the logFC values taken from the RNA-Seq, genes were 
initially mapped in accordance with their up- or down-regulation (Figure 15. logFC>0, 
overexpressed in blue and logFC<0, underexpressed in red). The idea was then to generate a 
distribution of the dysregulation pattern for each enriched function. For example, if “Generation 
of neurons” included 59 dysregulated genes, count how many of them have been presumably 
identified as over- and under-expressed. The plotted distribution evidenced that no abrupt 
changes are present for any enriched function (Figure 34). That is, the total number of 
dysregulated genes encountered for any enriched function is proportionally halved (up vs. 
down) for most of the cases. This scenario approximates to the idea that there exists a genetic 
expression balance, where the cellular functions potentially involved in a genodermatoses 
experience a state of equilibrium thanks to the cell’s ability to level over- and under- transcripts 
expression. 
 
FIGURE 34. COLUMN CHART EXHIBITING THE DYSREGULATION DISTRIBUTION FOR EACH ENRICHED FUNCTION 
FROM BINGO 
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5. DISCUSSION 
 
In a large extent, this project puts the spotlight on bioinformatics analysis to drive omics data 
integration from three phenotypically-related genordermatoses. The necessity for a convenient 
approach to work through massive omics data has been brought to the fore herein. To 
accomplish these endeavours, biological network construction has been proposed as a baseline. 
In this way, the generation of RNA graphs regulated by microRNAs has contributed to frame a 
global picture were mRNA expression and diversification for RDEB, KS and XPC are exposed. 
Networks allowed to perform system-level observations, ensuing in turn a narrowing-down 
strategy to finally identify certain candidate agents. These agents could eventually bring to light 
possible relations between lesser known genes and gear prospective blueprints towards them. 
To go over these agents, two approaches were used herein: the topological and the functional 
analyses. 
a. Topological characterization 
 
Even though there is not a clear consensus on how hubs can be identified or defined, network 
statistics definitely assist on the attempt to find and examine them. Topology provides bona fide 
results where novel candidate hub genes can be inspected. Once the hubs are recognized, one 
can make hypothesis regarding their essentiality on the graph structure. Understanding how the 
network behave when perturbations are introduced and targeted to the hubs is crucial to get 
phenotypic insights.  
With that said, one should note that the constructed graphs for RDEB/KS/XPC contain nodes 
that can represent either mRNAs or microRNAs, that is, they are bipartite graphs. This conditions 
the topological results, since the majority of the hubs turn out to be microRNAs: by removing 
them from the networks, the structure of the web is deeply compromised. This makes sense, 
since the main structure of the network is based on microRNAs and their mRNA targets. Clear 
examples of microRNA hubs are 1) MIMAT0000242, MIMAT0000461 and MIMAT0000253 for 
RDEB (which have been indeed validated with the RT-qPCR), 2) MIMAT0000242, 
MIMAT0000252 (validated), MIMAT0000461 and MIMAT0000681 (validated) for KS and 3) 
MIMAT0000646, MIMAT000075 and MIMAT0000242 for XPC. 
On the other side, certain genes have also been located as hubs for the studied networks. 
However, it should be noted that the Cytoscape algorithm which renders network properties 
(NetworkAnalyzer) is purely graph theoretical and uses no biological criteria, so the conclusions 
for gene hubs might not apply for other different biological networks, but they do for the 
RDEB/KS/XPC dysregulation networks constructed in this project. In this way, one can profile the 
candidate hub genes by the network they have been found in: 
RDEB: 
TIAM1 accounts for the gene with highest betweenness centrality, being connected to hub 
microRNAs and genes with high clustering coefficients (such as EPHA4, EFNA4 and LYN), so it 
should be remarked. Its value for betweenness centrality is closely followed by TFAP2A, or 
transcription factor AP-2, which exhibits as well a key interconnection with microRNAs and 
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relevant genes (Figure 16). TIAM1, EPHAs and EFNAs are molecules already studied which have 
showed to be entangled in skin inflammation processes and carcinogenesis [76]. 
By its part, ITGA8 presents the largest clustering coefficient, having tight connections with 
corresponding elements (Figure 17). ITGA8 is an integrin precursor protein, which shows PPIs 
with ITGB8 and FN1 (fibronectin). FN1, adds to the bargain a PPI with SDC1 gene, which 
translates into syndecans: transmembrane proteins that ligate with fibroblasts growth factors, 
among others [77]. In this way, Figure 17 manifests a conformation where two out of the three 
hallmarks of the genodermatoses common phenotype appear [19]: membrane and cell binding 
structures (integrins and syndecans) and inflammation (fibronectin). 
KS: 
BTG2 gene manifests silencing by two of the validated microRNAs (among others not validated): 
MIMAT0000461 and MIMAT0000681 (Figure 18). It is well-studied and have been recognised as 
a fundamental tumour suppressor [78]. With a shortest path length of 3.29, BTG2 presents an 
interesting silencing by 11 microRNAs, representing a strong communicative point within the KS 
graph. 
For the same reason, HOXA10 shows a similar arrangement (Figure 19): highly silenced by 13 
microRNAs and possessing a shortest path length of 3.27. HOXA10 gene downregulation has 
been observed in early stages of the human developmental process, being a critical regulator of 
megakaryocyte development (related again to inflammation responses) [79]. 
Regarding clustering coefficients, there is a conformation where SERPINE1, IGF2 and FN1 appear 
to work together. SERPINE1 is an inhibitor of fibrinolysis and IGF2 stands for the insulin-like 
growth factor 2, crucial for cellular growth and proliferation during embryogenesis [80]. These 
three molecules might mediate tightly a specific cellular function. Furthermore, the subgraphs 
exhibit connections with ITGB1 and ESR1. These connections of dysregulated transcripts might 
hold important information about KS loss-of-function events.  
Another subgraph is shown in Figure 20, this time with the largest clustering coefficient values 
for the KS network. Two elements should be highlighted: 1) SOCS1 is a suppressor of cytokine 
signalling through the JAK/STAT3 pathway [81], and appears to be a negative regulator in IGF1R 
signalling pathway. 2) Mutations in HERC3 have been associated with carcinomas [82]. Again, 
inflammation- and cancer proneness-related structures. 
XPC: 
STAT1 and HERC5 are ranked among the genes with larger degree values by the Cytoscape 
algorithm in the XPC microRNA → RNA network (degree=21 and 19 respectively). JAK/STAT 
signalling pathway has been previously associated with increased inflammation and oxidative 
stress (brain and skin aging). During cell signalling, it mediates integrin and actin filaments 
dynamics, affecting adhesion and cell movement [83]. By its part, HERC5 is required for 
interferon functioning during immune responses [84]). STAT1 and HERC5 are deeply embedded 
in a giant cluster found within the XPC graph (Figure 21). A remarkable number of PPIs has been 
found across it, and the majority of the genes are mapped with large clustering coefficients, as 
expected. Important information regarding this cluster might be downstream retrieved by 
refining the clustering tools. Agglomerative methods (based on degree) find only the core 
community, leaving out the periphery, which tends to be neglected [85]. A shift toward iterative 
algorithms where the edges with highest betweenness centralities are successively removed is 
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required for a better performance in finding cluster communities. That is why in this study only 
obvious-to-the-eye clusters have been interpreted. As a reflection for this cluster, it is important 
to point that large clusters do not necessarily group genes functionally, because it contains 
genes from many unrelated diseases. Alternatively, it indicates that complex phenotypes are 
entangled together genetically [85], which again proves the necessity of addressing the 
optimization of the clustering algorithms.  
ITGB1 shows a large degree in the XPC network (Figure 22): 16 edges with relevant PPIs such as 
FN1, more integrins (ITGB8 and ITGB3), TGFB1 (also known as Transforming Growth Factor Beta 
1), L1CAM and several inhibitory microRNAs. Special attention deserves L1CAM gene, which 
provides instructions for producing the L1 cell adhesion molecule. L1 has shown adhesive roles 
in cell-cell interactions and associates with β1 integrins on the cell surface to induce cell surface 
signalling, stimulating thus cell migration and outgrowth [86]. 
Finally, other top-ranked gene nodes in what betweenness centrality means deserve emphasis 
as well (Figure 23): 1) ESR1, or estrogen receptor 1, is tightly linked to FN1 and TFAP2A (among 
others). In addition, it is regulated by the validated MIMAT0000242. Besides, TFAP2A shows 
silencing by validated MIMAT0000461. 2) FN1 cluster manifest relationships with four different 
integrin family members (ITGB1, ITGB3, ITGB4, ITGB8) and with VEGFB, among others. Vascular 
Endothelial Growth Factor B (VEGFB) has been widely studied: it is a ligand for neutropilin-1 and 
is associated with platelets. In addition, diseases like macular degeneration, aging and focal 
adhesions relate to VEGFB, which prove phenotypically relevance on the genodermatoses 
disorders [87]. 
TABLE 6. TOPOLOGICAL RESULTS (HUB GENES) 
microRNA-RNA network Topological results (hub genes) 
RDEB TIAM1  TFAP2A  ITGA8  ITGB8  FN1  SDC1 
KS BTG2  HOXA10  SERPINE1  IGF2  FN1  ESR1  SOCS1  HERC3 
XPC STAT1  HERC5  ITGB1  L1CAM  ESR1  FN1  TFAP2A  VEGF 
 
Aforementioned RNAs stand for relevant candidates for further research. Their individual 
topological parameters (computed at Cytoscape) allow to describe them as hubs for the 
RDEB/KS/XPC constructed networks.  To do so, values for degree, betweenness centrality and 
shortest path distance have been considered regardless of previous biases. Network properties 
influence the likelihood and phenotypic consequences of disease mutations. For that reason, if 
a random perturbation were introduced in the microRNAs-RNAs networks, graph tolerance 
would be higher if hubs were not compromised. That is, a perturbation that affected the hubs 
would quickly spread through the network. These bipartite graphs are widely governed by the 
hubs, where in the majority of the cases, microRNAs control the interconnections, and only a 
few RNAs partake in the topological properties. The ratio of microRNA/RNA nodes is notably 
small, so the bipartition is not equally distributed: many RNAs link to few microRNAs, and some 
transcripts interconnections turn out to be PPIs. According to this system, the underexpression 
of microRNA is related to an overexpression of its targeted genes. The absence of a microRNA 
would enable the transcripts (RNAs) to express and codify the final protein [55], and viceversa: 
if a microRNA is up-regulated, it will largely silence its targeted transcripts, impeding the 
translation into proteins. This would bring huge decompensations in the normal functioning of 
the analysed fibroblasts for RDEB/KS/XPC patients. 
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Furthermore, global topological results provide with more valuable insights as well: the 
clustering coefficient is significantly higher than expected from random chance, the small 
average shortest path length and the appropriate density values allows us to conclude that our 
merged networks are actually real-world. Under this premise, they might experience 
preferential attachment, a process where “rich nodes get richer” [14], that is, microRNAs would 
target even more genes and hub genes, by their part, would present new PPIs. In other words, 
the presumable power-law distribution (Figure 2) would endorse the point made herein. High 
degree nodes tend to attach to low degree nodes, and this disassortativity event has been 
proved typical for biological networks [14]. In this way, the aforementioned genes identified as 
hubs would be able to reveal “guilty by association” connections to other genes. In other words, 
they might predict the cellular function of up-to-now unknown proteins. 
In conclusion, topology helps to identify biomarkers which correspond in turn to active hotspots 
for further analysis.      
b. Functional characterization 
 
It is important to highlight that both initial Enrichment widgets (BiNGO & STRING) sort every 
term by a p-value obtained from a Hypergeometric test, that is corrected by the Benjamini and 
Hochberg FDR method [67]. That is, they follow a similar statistical approach. Despite following 
analogous algorithms, one can consider STRING being more complete since it provides more 
orthology information (by invoking more knowledge databases such as KEGG and InterPro).  
Enriched functions from both plug-ins have been studied in tandem. Grouping by semantic 
similarity (ReVIGO) has sustained the project was on the right track. Enriched functions for the 
RDEB/KS/XPC gene lists were identified. By curating only those functions which had been 
enriched with genes from the three genodermatoses simultaneously (Figure 33), a definite 
record was reached out, including exclusively functions presumably shared by the three skin 
disorders together.  
A final observation of the dysregulated genes in the enrichment analysis (Figure 34) was also 
performed. Each gene associated to an enriched function was assessed in terms of its logFC, 
which can hold either a positive (over-expressed) or a negative value (under-expressed). Overall, 
the functional profile manifests a paired fashion, where the number of up-regulated genes 
appear to compensate the amount of down regulation. For the majority of the enriched 
functions, there is a balance on gene expression. On this basis, one can argue that cells carry out 
compensatory mechanisms by which their resilience to outweigh abrupt dysregulatory 
challenges is effective. This steady state of internal conditions is called homeostasis [30], and 
can be hypothesized that the number of PPIs in each system help in these compensatory 
mechanisms by transmitting the information and regulatory processes across the network. 
This constituted a turning point, from which final Cytoscape analyses could be undergone. In 
fact, ClueGO plug-in showed a perfect match for the desired exercise, since it is able to make 
use of REACTOME to concentrate on very specific terms, especially those from transcriptional 
control. In this way, and employing downstream enrichment analysis, REACTOME provided with 
hits that were successively allocated in a worksheet (Table 4 and Table 5). The hits provided by 
REACTOME confirmed several of the genes highlighted in the topological analysis, as well as 
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pointed out certain mechanisms related to the three phenotypical hallmarks of our 
genodermatoses. 
Cell adhesions: 
Elements crucial for tissue architecture are highlighted as hits in the REACTOME results. 
Concretely, “elastic fiber formation”, TFAP2A, Integrins & Syndecans, Neutropilin, VEGF, L1, 
EPHAs and TIAM1.  
-Elastic fibers are bundles of proteins produced by fibroblasts and secreted in the extracellular 
matrix of connective tissues, conferring biomechanical elasticity and resilience to them [88]. 
COL7A1 and kindlin-1 fall within this class of molecules. Additionally, they are a major 
contributor in the degenerative changes in sun-damaged skin [89], which relates to XPC 
disorder. 
-TFAP2A, mentioned above, exerts influence on proper body wall development and coordinates 
keratinocyte proliferation and differentiation. Plus, it has been related already to melanoma 
progression [90] 
- Integrins and syndecans experience a synergistic control of cell adhesion [77], regulating cell 
behavior in response to the external environment too. These large complexes of cell surface 
receptors allow for growth factor activation and tumour suppression and progression, among 
others.  
-Semaphorins are versatile proteins associated with axon guidance and neural system 
development. Besides, some classes can regulate integrins and have specific roles in immune 
function [91] 
-Neutropilin is a protein receptor active in neurons. It is a co-receptor for semaphorins, having 
a combined role in the nervous system development in vertebrates [92]. As stated in the 
worksheet (Tables 4 & 5), neutropilin interacts with VEGF. 
-VEGF, or vascular endothelial growth factor, is an important signaling protein involved in 
angiogenesis and immune response. VEGF has been seen to stimulate SDC1 to capture 
epidermal growth factor receptors [93]. Platelets has been observed to accumulate and 
transport VEGF in cancer patients [87] 
-L1, mentioned in topological results as well, attains adhesive roles in cell-cell interactions. It 
provides neurons with cues in order to drive axonal growth and guidance. It is also able to 
associate with integrins and binds the SEMA3A receptor neutropilin-1 (partially reversing the 
effects of VEGF, [93]) 
-EPHA is closely related to TIAM1 by mediating neurite outgrowth. The best documented 
function of its signaling is the cell adhesion, positioning and migration. It has previously shown 
skin inflammation [76] 
-TIAM1 deficiency protects again Ras-1 induced skin carcinogenesis. Its dysregulation causes 
tumor onset and progression. TIAM1 has been associated to hemidesmosomes and focal 
adhesions on epidermolysis bullosa and kindler syndrome [94]. 
Inflammatory processes: 
-Chemokines are a family of small cytokines that induce directed chemotaxis, recruiting cells of 
the immune system and conducting them to a site of infection [30]. All of them interact with 
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transmembrane receptors and have different roles: from controlling lymphocytes response to 
promoting angiogenesis, although they are functionally divided into homeostatic and 
inflammatory. 
-NR-MED1 coactivator complex has been related to integrin and PI3K signaling events. MED1 
functions as a nuclear receptor coactivator, and its overexpression regulates the expression of 
proinflammatory chemokines [95]. 
Cancer proneness: 
-NOTCH is a well-studied epidermal growth factor, having broad roles in neurogenesis, 
angiogenesis, cardiac functioning and bone regeneration. NOTCH signaling is known to occur 
inside ciliated, differentiating cells found in the first epidermal layers during early skin 
development [96].  
-PI3Ks are a family of enzymes involved in a wide range of cellular functions, all of them resulting 
in cancer. It has got pathways intertwined with NOTCH. As signal transducer, it is implicated in 
a tumor insensitivity pathway. Its tight relation to the epidermal growth factor receptor (EGFR) 
has appeared in cancer studies [97]. 
-Interleukin, as well as chemokines, are a group of cytokines that mediate immune responses (T 
cell signaling). Intracellular networks describe connections where different types of interleukins 
activate PI3K and relates to tumor cell survival [30]. 
-The exocytosis of platelets plays a critical role in different aspects of the immune response 
(hemostasis, thrombosis, vascular remodeling and healing). In fact, platelets are related to Ras 
oncogenes, besides being used in skin wound healing [87]. 
-SCF-KIT stands for a pathway that plays a crucial role in the human melanocyte homeostasis 
[97].  SCF is expressed by fibroblasts, promoting proliferation, survival, migration and 
differentiation of melanocyte progenitors. KIT stimulation activates PI3K pathway, among 
others.  
Some of the genes involved in the aforementioned complexes and structures can be actually 
ubicated within the constructed transcriptional regulatory networks (Table 7). Provided that 
they are contained in the graphs, their expression values are statistically different from those 
observed in the healthy samples. In the light of this, it can be argued that the three skin disorders 
might register certain phenotypic convergences under those transcriptional alterations. 
Highlighted genes in Table 7 refer to nodes common to the three networks, understood as 
differentially expressed transcripts. 
TABLE 7. FUNCTIONAL RESULTS FROM REACTOME 
microRNA-RNA network Functional results from REACTOME (corresponding genes) 
RDEB ITGA8 ITGB8 EPHA4 KIT L1CAM SDC1 SEMA4G TFAP2A TIAM1 
KS ITGB1 KIT L1CAM SEMA4D TFAP2A TIAM1 
XPC EPHA2 EPHA4 ITGB1 ITGB3 ITGB8 L1CAM SEMA4C SEMA4D 
TFAP2A VEGFB 
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c. Unifying topological & functional results 
 
A remark needs to be taken in what topological and functional outcomes concerns. Their kind is 
different, so is its origin: topology comes from the purest graphical point of view, whereas 
functional results make use of enrichment strategies to invoke ontologies and databases from 
which matched biological processes, molecular functions and cellular components are retrieved. 
Among the Computational Biology community, there is a postulation that defends essential and 
disease genes show qualitative different behaviour. Essentiality were to be a topology-related 
aspect, whereas function-related anomalies within the networks were to be attributed to 
disease genes. According to this perception, disease genes would avoid dense-clustering 
neighborhoods unlike the essential genes, because the formers would tend to escape most vital 
cellular components while affecting lesser physiological processes [98]. In this manner, disease 
mutations could preferentially occur in non-essential genes for the network. Anyway, the 
approach followed in this work contemplates topology and functional analyses regardless of 
distinctions, where genes are considered as equally relevant whatever they were retrieved 
either from topological or functional analysis. Both of them deserve attention and discussion, 
since no previous bias was upheld. 
Notwithstanding, a meeting point is identified for this particular genodermatoses study. 
According to both algorithms, some differentially expressed entities, here represented as 
specific nodes, are acknowledged as relevant within the gene lists and biological networks 
constructed. Concretely, L1CAM, TFAP2A are highlighted both from topology and functional 
enrichment analyses. By these means, and having a look at their connections at the constructed 
biological networks, final insights are gained (Table 8): 
In RDEB network, L1CAM is underexpressed (logFC=-5.078), and regulated by the validated 
microRNA MIMAT0000242 (hsa-miR-129-5p) which, in turn, is overexpressed (logFC=3.604). 
In KS network, L1CAM is underexpressed (logFC=-5.724), and regulated by the validated 
microRNA MIMAT0000242 (hsa-miR-129-5p) which, in turn, is overexpressed (logFC=3.582) 
In XPC network, L1CAM is underexpressed (logFC=-7.364), and regulated by the validated 
microRNA MIMAT0000242 (hsa-miR-129-5p) which, in turn, is overexpressed (logFC=3.999). 
Other microRNAs seem to be silencing L1CAM, all of them showing overexpression 
(MIMAT0000449 logFC=3.763, MIMAT0000727 logFC=1.135, MIMAT0022925 logFC= 1.662, 
MIMAT0004494 logFC=1.419).  
In RDEB network, TFAP2A is underexpressed (logFC=-3.635), and regulated by the validated 
microRNAs MIMAT0004555 (hsa-miR-10a-3p) and MIMAT000461 (hsa-miR-195-5p) (among 
others) which, in turn, are overexpressed (logFC=8.590 and logFC=2.555) 
In KS network, TFAP2A is underexpressed (logFC=-3.41), and regulated by the validated 
microRNAs MIMAT0004555 (hsa-miR-10a-3p) and MIMAT000461 (hsa-miR-195-5p) (among 
others) which, in turn, are overexpressed (logFC=9.535 and logFC=2.936) 
In XPC network, TFAP2A is underexpressed (logFC=-4.636), and regulated by the validated 
microRNAs MIMAT0004555 (hsa-miR-10a-3p) and MIMAT000461 (hsa-miR-195-5p) (among 
others) which, in turn, are overexpressed (logFC=9.483 and logFC=3.149) 
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It is important to recall that this whole project takes off from microRNAs. They have been the 
bedrock for all the actions and analyses carried out. That is why a look back was needed. Being 
able to come to an end by highlighting relevant microRNAs (Table 8) for further studies, is a 
matter of good sense. 
 
 
TABLE 8. L1CAM & TFAP2A BEHAVIOUR IN THE BIOLOGICAL NETWORKS 
 
 L1CAM TFAP2A 
RDEB   
KS   
XPC   
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6. SOCIO-ECONOMIC IMPACT 
 
Rare Disorders are considered as such due to their low prevalence in the population (less than 
5 in 10.000 inhabitants). However, The World Health Organization (WHO) calculates that about 
7.000 Rare Disorders affect 7% of individuals, globally. FEDER (Federación Española de 
Enfermedades Raras) estimates that over 3 million people currently suffer from Rare Disorders 
in Spain, impairing their physical, mental and behavioural faculties with different degrees of 
disability. These pathologies are, for the most part, chronic and degenerative. They deprive self-
sufficiency and autonomy, compromising quality of life and even its expectancy in some cases 
(35% of Rare Disorder patient deaths occur in the first year of life [99]). 
Specifically, RDEB, KS and XPC correspond to inherited skin disorders where respective 
mutations in proteins COL7A1, FERMT1 and XPC impede to reach a curative treatment for the 
moment. Gene therapy can be provided in some cases today (throughout Recombinant DNA 
Technologies [100]) where the genomic mutation is corrected in stem cells and infused 
afterwards in the patient. Yet, this experimental technique is not extended to the clinics, and 
therefore, discovery of biomarkers and possible drug targets for symptom alleviation is needed. 
Studies like this one, represent a blueprint where system-level observations lead to new insights 
about the molecular mechanisms that are entangled in the shared signature of the 
genodermatoses. By doing so, and employing a bioinformatics approach, the scientific 
community can take advantage of omics data, generating information and eventually gaining 
perspectives on the cellular functioning.  
The identification of potential candidate genes or microRNAs whose mechanisms and 
interactions might be involved in the common hallmarks of RDEB/KS/XPC (skin fragility, 
inflammation and cancer proneness) gives a prospective opportunity for the development of 
new drugs that could target specific structures and processes within tissues, serving as a 
palliative treatment for the genodermatoses and improving thus the quality of life and the 
patients.  
On the other hand, by carrying out bioinformatic studies to approach Rare Disorders, economic 
costs are being reduced substantially. Narrowing-down strategies allow to rule out a huge 
number of molecules, validating thus only the promising ones in the lab. Bioinformatic analyses 
stand as an efficient tool where time-consuming research procedures can be shortened, 
scientific knowledge can be expanded and palliative treatments developed without directly 
compromising the patient’s state. Besides, bioinformatic studies are not dramatically affected 
by the lack of funding in research, since resources like laboratory equipment and devices are not 
necessarily needed throughout the whole line of research, and NGS technologies are already 
benefiting from a standardized use and reduction in prices. 
The positive bioinformatic advantages seem to be quite obvious, having a hopeful influence in 
health and clinical needs. However, computational algorithms require capital and upgrading 
investment in order to provide more accurate and refined bioinformatic results, decreasing thus 
the false positives rate and making the effort worthwhile. In the same way, public 
bioinformation infrastructure seems inadequate, so massive data storage and accessibility 
demands higher equity injections. 
The estimated budget to carry out the thesis project is indicated in Table 9. 
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TABLE 9. ESTIMATED EXPENDITURE ON THE RESEARCH PROJECT 
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7. CONCLUSIONS AND FUTURE DIRECTIONS 
 
MicroRNA-RNA networks are poorly understood today. Not only this type of graphs, but in 
general the analysis of integrated biological networks. Their bipartite nature entails a challenge 
when facing analytical approaches to extract useful information and to convey, eventually, a 
biological interpretation out of the omics data integration. The differences between 
epigenomics and transcriptomics are latent, but not exclusionary. Both records can be combined 
and assessed conjointly in an attempt to offer a bioinformatics solution for high-throughput data 
orchestration. Engaging with NGS technologies implies continuous improvements and 
discoveries on cellular mechanisms and medical conditions. It is all about data and its 
consistency. Merging strategies by repository curation and data cross-referencing ensures high 
standards, leading ultimately to a unified method through which scaling-up approaches could 
be applied to other systems and lines of research, extending its reproducibility. In this particular 
case, a potential way to engender trust in data and guarantee the proper value of integrative 
bioinformatics, metabolomics data could be incorporated: metabolic pathways described in 
biological literature still preserves hidden cellular knowledge. Metabolites suffer a magnified 
amplification of the effects occurring at the transcriptome and proteome level, so their 
information is very reliable, due to its closeness to the phenotype. It represents a crosstalk 
between Epigenetics and Metabolomics. Upon its integration, biological networks can be 
satisfactorily sharpened and biomarkers can be sufficiently refined to allow for drug repurposing 
approaches. By meeting these necessities, bioinformatic investigation might position itself in a 
cutting-edge Information Technology strategy to complement, and even strengthen, biomedical 
sciences. 
In this project, a global approach to the analysis of networks was performed, providing valuable 
information regarding tentative biomarkers and functional mechanisms that can partially 
explain some of the common phenotypic hallmarks shared by three genodermatoses. This 
approach allows to further generate new hypothesis (that must be eventually validated) and 
opens new fields of research in terms of development of drugs (or drug repurposing) that could 
target these highlighted genes or miRNAs and therefore mitigate some of the symptoms of these 
diseases. 
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ANNEX 
  
TABLE WITH THE 27 SIGNIFICANT MICRORNAS IN RDEB VS HEALTHY 
Gene_id logFC PValue FDR 
hsa-miR-10a-5p 8.824 5.040E-13 6.310E-10 
hsa-miR-10a-3p 8.590 1.107E-12 6.931E-10 
hsa-miR-556-5p -4.536 1.383E-11 5.772E-09 
hsa-miR-6507-5p -4.779 5.103E-08 1.597E-05 
hsa-miR-6842-3p -2.425 7.527E-08 1.885E-05 
hsa-miR-195-3p 2.902 3.217E-07 6.712E-05 
hsa-miR-556-3p -3.859 7.267E-07 1.300E-04 
hsa-miR-129-5p 3.604 1.863E-06 2.915E-04 
hsa-miR-129-2-3p 2.975 4.151E-06 5.774E-04 
hsa-miR-29b-2-5p -2.150 7.285E-06 8.440E-04 
hsa-miR-10b-5p 4.379 7.415E-06 8.440E-04 
hsa-miR-29c-5p -1.901 1.737E-05 1.813E-03 
hsa-miR-29c-3p -2.172 2.798E-05 2.694E-03 
hsa-miR-10b-3p 4.185 3.675E-05 3.286E-03 
hsa-miR-1295a -3.015 6.489E-05 5.416E-03 
hsa-miR-4488 -2.192 7.257E-05 5.679E-03 
hsa-miR-615-3p 3.925 8.503E-05 6.262E-03 
hsa-miR-148a-5p 2.112 1.078E-04 7.499E-03 
hsa-miR-146b-5p -1.976 1.146E-04 7.552E-03 
hsa-miR-615-5p 4.028 2.479E-04 1.531E-02 
hsa-miR-874-5p -1.612 2.686E-04 1.531E-02 
hsa-miR-497-5p 2.303 2.690E-04 1.531E-02 
hsa-miR-195-5p 2.555 5.443E-04 2.931E-02 
hsa-miR-935 -2.624 5.618E-04 2.931E-02 
hsa-miR-629-3p 1.973 6.219E-04 3.011E-02 
hsa-miR-148a-3p 2.069 6.253E-04 3.011E-02 
hsa-miR-1468-5p -2.008 6.669E-04 3.092E-02 
 
 
 
 
 
 
 
 
 
67 
TABLE WITH THE 99 SIGNIFICANT MICRORNAS IN KS VS HEALTHY 
Gene_id logFC PValue FDR 
hsa-miR-1291 5.774 1.049E-17 1.011E-14 
hsa-miR-10a-5p 10.496 2.217E-17 1.069E-14 
hsa-miR-1260a 5.360 1.503E-15 4.830E-13 
hsa-miR-10a-3p 9.535 3.761E-13 9.064E-11 
hsa-miR-483-3p -6.817 6.627E-13 1.278E-10 
hsa-miR-483-5p -7.343 1.383E-12 2.221E-10 
hsa-miR-556-5p -6.282 4.896E-12 6.742E-10 
hsa-miR-3607-5p 4.149 8.124E-11 9.789E-09 
hsa-miR-1295a -4.676 2.420E-09 2.593E-07 
hsa-miR-1468-5p -3.589 3.161E-08 3.047E-06 
hsa-miR-129-5p 3.582 4.865E-08 4.263E-06 
hsa-miR-129-2-3p 3.237 1.004E-07 7.597E-06 
hsa-miR-1247-5p -5.513 1.025E-07 7.597E-06 
hsa-miR-3605-3p -2.427 1.662E-07 1.144E-05 
hsa-miR-7974 2.918 3.096E-07 1.989E-05 
hsa-miR-6842-3p -2.770 6.803E-07 3.773E-05 
hsa-miR-10b-5p 5.137 7.019E-07 3.773E-05 
hsa-miR-29c-3p -2.119 7.044E-07 3.773E-05 
hsa-miR-148a-3p 2.276 1.562E-06 7.927E-05 
hsa-miR-3615 -2.124 4.902E-06 2.363E-04 
hsa-miR-137 2.503 5.442E-06 2.498E-04 
hsa-miR-195-5p 2.936 6.427E-06 2.816E-04 
hsa-miR-6507-5p -5.372 7.726E-06 3.108E-04 
hsa-miR-3184-3p -1.852 7.739E-06 3.108E-04 
hsa-miR-31-3p 1.948 1.090E-05 4.202E-04 
hsa-miR-561-5p -1.929 1.152E-05 4.271E-04 
hsa-miR-3529-3p 2.033 1.671E-05 5.965E-04 
hsa-miR-4767 2.362 1.929E-05 6.641E-04 
hsa-miR-10b-3p 4.932 2.146E-05 7.088E-04 
hsa-miR-4517 2.388 2.206E-05 7.088E-04 
hsa-miR-4653-5p 3.374 2.941E-05 9.145E-04 
hsa-miR-221-5p 1.722 4.374E-05 1.318E-03 
hsa-miR-29b-2-5p -2.095 5.826E-05 1.702E-03 
hsa-miR-877-5p -1.821 6.856E-05 1.944E-03 
hsa-miR-142-5p 3.386 8.156E-05 2.162E-03 
hsa-miR-149-5p -1.864 8.172E-05 2.162E-03 
hsa-miR-5701 -6.849 8.297E-05 2.162E-03 
hsa-miR-155-3p 3.482 1.150E-04 2.918E-03 
hsa-miR-142-3p 3.617 1.246E-04 3.081E-03 
hsa-miR-181a-5p -1.970 1.466E-04 3.533E-03 
hsa-let-7i-3p 1.954 1.542E-04 3.625E-03 
hsa-miR-548ab -1.939 2.066E-04 4.735E-03 
68 
hsa-miR-133a-3p -3.795 2.112E-04 4.735E-03 
hsa-miR-328-3p -1.558 2.410E-04 5.281E-03 
hsa-miR-128-3p -1.500 2.565E-04 5.495E-03 
hsa-miR-4521 2.209 2.626E-04 5.504E-03 
hsa-miR-624-5p 2.134 2.851E-04 5.847E-03 
hsa-miR-1305 2.312 3.011E-04 6.047E-03 
hsa-miR-100-3p 1.602 3.220E-04 6.336E-03 
hsa-miR-629-3p 1.893 3.352E-04 6.463E-03 
hsa-miR-98-3p -1.439 3.613E-04 6.830E-03 
hsa-miR-6784-3p -2.060 4.059E-04 7.525E-03 
hsa-miR-1247-3p -6.422 4.445E-04 8.085E-03 
hsa-miR-148a-5p 2.012 4.925E-04 8.792E-03 
hsa-miR-887-3p -1.571 5.145E-04 9.019E-03 
hsa-miR-454-5p -1.491 5.389E-04 9.276E-03 
hsa-miR-326 -1.541 5.721E-04 9.564E-03 
hsa-miR-556-3p -3.428 5.754E-04 9.564E-03 
hsa-miR-7-5p 2.166 6.960E-04 1.137E-02 
hsa-miR-145-5p 1.770 7.213E-04 1.159E-02 
hsa-miR-6868-3p -2.724 7.424E-04 1.173E-02 
hsa-miR-6737-3p -1.711 7.964E-04 1.238E-02 
hsa-miR-6769b-3p -1.581 8.849E-04 1.354E-02 
hsa-miR-19b-1-5p 1.875 9.072E-04 1.367E-02 
hsa-miR-496 1.472 9.418E-04 1.397E-02 
hsa-miR-195-3p 2.011 1.012E-03 1.478E-02 
hsa-miR-1972 1.740 1.148E-03 1.652E-02 
hsa-miR-135b-5p 2.387 1.179E-03 1.671E-02 
hsa-miR-1268a 1.630 1.202E-03 1.679E-02 
hsa-miR-6716-3p -1.554 1.219E-03 1.679E-02 
hsa-miR-144-5p -2.106 1.414E-03 1.910E-02 
hsa-miR-3677-3p 1.400 1.426E-03 1.910E-02 
hsa-miR-615-3p 3.246 1.502E-03 1.983E-02 
hsa-miR-423-3p -1.340 1.523E-03 1.984E-02 
hsa-miR-1910-5p -1.637 1.549E-03 1.991E-02 
hsa-miR-5683 3.181 1.585E-03 2.011E-02 
hsa-miR-605-5p 1.655 1.665E-03 2.085E-02 
hsa-miR-3152-5p 2.936 1.835E-03 2.242E-02 
hsa-miR-196b-5p -1.531 1.842E-03 2.242E-02 
hsa-miR-573 2.556 1.861E-03 2.242E-02 
hsa-miR-130b-5p -1.310 2.000E-03 2.380E-02 
hsa-miR-4803 2.149 2.079E-03 2.444E-02 
hsa-miR-2116-3p -1.470 2.124E-03 2.467E-02 
hsa-miR-33b-5p -1.445 2.184E-03 2.506E-02 
hsa-miR-668-3p -1.428 2.447E-03 2.775E-02 
hsa-miR-6750-3p -2.200 2.513E-03 2.817E-02 
hsa-miR-3152-3p 2.117 2.664E-03 2.952E-02 
69 
hsa-miR-4731-3p 2.260 2.792E-03 3.059E-02 
hsa-miR-423-5p -1.194 3.026E-03 3.278E-02 
hsa-miR-106b-3p -1.241 3.327E-03 3.531E-02 
hsa-miR-153-3p -2.482 3.350E-03 3.531E-02 
hsa-miR-34c-3p 1.376 3.369E-03 3.531E-02 
hsa-miR-365a-3p 1.176 3.514E-03 3.642E-02 
hsa-miR-6824-3p -1.627 3.600E-03 3.691E-02 
hsa-miR-29c-5p -1.312 3.797E-03 3.853E-02 
hsa-miR-3157-5p 2.022 3.860E-03 3.876E-02 
hsa-miR-656-5p 1.817 4.191E-03 4.165E-02 
hsa-miR-3613-3p 1.315 4.278E-03 4.208E-02 
hsa-miR-1254 -1.344 4.758E-03 4.633E-02 
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TABLE WITH THE 148 SIGNIFICANT MICRORNAS IN XPC VS HEALTHY 
Gene_id logFC PValue FDR 
hsa-miR-10a-5p 10.442 4.086E-74 3.641E-71 
hsa-miR-10a-3p 9.483 1.155E-44 5.144E-42 
hsa-miR-1260a 7.239 1.617E-23 4.803E-21 
hsa-miR-6087 6.211 2.032E-14 4.526E-12 
hsa-miR-129-5p 3.999 2.297E-13 4.093E-11 
hsa-miR-129-2-3p 3.639 4.422E-13 6.567E-11 
hsa-miR-195-5p 3.149 2.842E-10 3.618E-08 
hsa-miR-1295a -5.668 2.501E-09 2.785E-07 
hsa-miR-1291 5.148 1.005E-08 9.951E-07 
hsa-miR-6842-3p -3.317 3.823E-08 3.186E-06 
hsa-miR-10b-5p 5.152 3.934E-08 3.186E-06 
hsa-miR-155-3p 4.731 5.253E-08 3.900E-06 
hsa-miR-1468-5p -3.251 1.197E-07 8.207E-06 
hsa-miR-137 2.870 2.004E-07 1.266E-05 
hsa-let-7i-3p 2.504 2.300E-07 1.266E-05 
hsa-miR-5683 5.262 2.316E-07 1.266E-05 
hsa-miR-556-5p -4.168 2.493E-07 1.266E-05 
hsa-miR-146a-5p 3.763 2.557E-07 1.266E-05 
hsa-miR-3607-5p 3.859 6.783E-07 3.181E-05 
hsa-miR-148a-3p 2.188 8.616E-07 3.838E-05 
hsa-miR-147b 3.088 1.132E-06 4.802E-05 
hsa-miR-548ab -2.636 1.697E-06 6.873E-05 
hsa-miR-877-5p -2.057 3.409E-06 1.321E-04 
hsa-miR-4454 2.278 4.725E-06 1.754E-04 
hsa-miR-10b-3p 4.989 4.996E-06 1.781E-04 
hsa-miR-100-3p 1.974 5.690E-06 1.950E-04 
hsa-miR-195-3p 2.365 6.012E-06 1.984E-04 
hsa-miR-3605-3p -1.940 1.082E-05 3.442E-04 
hsa-miR-3117-3p 2.637 1.236E-05 3.798E-04 
hsa-miR-19b-1-5p 2.456 1.423E-05 4.221E-04 
hsa-miR-142-5p 2.802 1.468E-05 4.221E-04 
hsa-miR-483-5p -4.169 2.110E-05 5.876E-04 
hsa-miR-1247-5p -4.264 2.401E-05 6.481E-04 
hsa-miR-7974 2.170 2.798E-05 7.331E-04 
hsa-miR-146a-3p 6.520 3.530E-05 8.987E-04 
hsa-miR-15a-3p 2.503 3.795E-05 9.392E-04 
hsa-miR-3615 -1.724 3.980E-05 9.585E-04 
hsa-miR-4524a-5p 2.469 4.376E-05 1.026E-03 
hsa-miR-3184-3p -1.577 4.560E-05 1.042E-03 
hsa-miR-129-1-3p 5.018 4.733E-05 1.054E-03 
hsa-miR-3614-5p 4.423 5.032E-05 1.078E-03 
hsa-miR-155-5p 1.753 5.080E-05 1.078E-03 
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hsa-miR-4488 -3.355 5.820E-05 1.206E-03 
hsa-miR-4473 -2.102 6.801E-05 1.377E-03 
hsa-miR-891a-5p 7.110 7.145E-05 1.415E-03 
hsa-miR-183-5p 3.802 7.650E-05 1.482E-03 
hsa-miR-6507-5p -6.470 8.237E-05 1.561E-03 
hsa-miR-624-5p 2.423 9.000E-05 1.671E-03 
hsa-miR-561-5p -1.840 9.521E-05 1.731E-03 
hsa-miR-4517 2.201 1.018E-04 1.814E-03 
hsa-miR-196b-5p -1.569 1.115E-04 1.948E-03 
hsa-miR-142-3p 2.619 1.261E-04 2.160E-03 
hsa-miR-454-5p -1.637 1.286E-04 2.162E-03 
hsa-miR-1908-3p -2.026 1.415E-04 2.334E-03 
hsa-miR-668-3p -1.885 1.965E-04 3.183E-03 
hsa-miR-615-3p 3.474 2.180E-04 3.468E-03 
hsa-miR-3529-3p 1.677 2.483E-04 3.882E-03 
hsa-miR-615-5p 3.663 2.771E-04 4.257E-03 
hsa-miR-21-3p 1.419 3.466E-04 5.234E-03 
hsa-miR-4773 1.970 3.713E-04 5.513E-03 
hsa-miR-6737-3p -2.056 4.175E-04 6.098E-03 
hsa-miR-98-3p -1.477 4.295E-04 6.173E-03 
hsa-miR-146b-3p -2.345 4.685E-04 6.625E-03 
hsa-miR-874-5p -1.858 4.786E-04 6.654E-03 
hsa-miR-326 -1.874 4.891E-04 6.654E-03 
hsa-miR-31-3p 1.421 4.929E-04 6.654E-03 
hsa-miR-34c-3p 1.744 5.020E-04 6.676E-03 
hsa-miR-20a-5p 1.370 5.965E-04 7.816E-03 
hsa-miR-487b-3p -1.321 6.156E-04 7.933E-03 
hsa-miR-486-3p -1.808 6.257E-04 7.933E-03 
hsa-miR-887-3p -1.518 6.321E-04 7.933E-03 
hsa-miR-3613-3p 1.528 7.211E-04 8.924E-03 
hsa-miR-1268a 1.681 7.725E-04 9.428E-03 
hsa-miR-149-5p -1.478 8.263E-04 9.949E-03 
hsa-miR-19a-5p 2.202 9.320E-04 1.107E-02 
hsa-miR-549a -1.617 1.017E-03 1.192E-02 
hsa-miR-431-3p -1.369 1.090E-03 1.261E-02 
hsa-miR-4767 2.370 1.157E-03 1.322E-02 
hsa-miR-6868-3p -2.539 1.183E-03 1.334E-02 
hsa-miR-29b-2-5p -1.709 1.226E-03 1.358E-02 
hsa-miR-3613-5p 1.427 1.235E-03 1.358E-02 
hsa-miR-1299 2.329 1.286E-03 1.398E-02 
hsa-miR-6747-3p -2.775 1.305E-03 1.401E-02 
hsa-miR-328-3p -1.237 1.607E-03 1.704E-02 
hsa-miR-16-1-3p 1.630 1.719E-03 1.802E-02 
hsa-miR-424-5p 1.460 1.743E-03 1.806E-02 
hsa-miR-1233-3p -3.758 1.870E-03 1.915E-02 
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hsa-miR-2116-3p -1.627 1.915E-03 1.939E-02 
hsa-miR-128-3p -1.219 1.999E-03 2.001E-02 
hsa-miR-585-5p 1.921 2.038E-03 2.018E-02 
hsa-miR-944 6.216 2.108E-03 2.062E-02 
hsa-miR-483-3p -2.997 2.129E-03 2.062E-02 
hsa-miR-5701 -4.472 2.164E-03 2.074E-02 
hsa-miR-548h-3p 1.768 2.236E-03 2.120E-02 
hsa-miR-3194-5p 3.070 2.352E-03 2.195E-02 
hsa-miR-503-3p 1.662 2.365E-03 2.195E-02 
hsa-miR-584-5p -1.178 2.488E-03 2.263E-02 
hsa-miR-1270 1.620 2.498E-03 2.263E-02 
hsa-miR-4524a-3p 2.686 2.515E-03 2.263E-02 
hsa-miR-6787-3p -2.832 2.566E-03 2.287E-02 
hsa-miR-548t-3p 1.652 2.616E-03 2.308E-02 
hsa-miR-181a-5p -1.479 2.711E-03 2.368E-02 
hsa-miR-486-5p -1.578 2.776E-03 2.399E-02 
hsa-miR-1296-3p 1.947 2.800E-03 2.399E-02 
hsa-miR-744-5p -1.171 2.866E-03 2.420E-02 
hsa-miR-431-5p -1.139 2.920E-03 2.420E-02 
hsa-miR-133a-3p -2.232 2.928E-03 2.420E-02 
hsa-miR-423-3p -1.118 2.933E-03 2.420E-02 
hsa-miR-548z 1.907 3.125E-03 2.554E-02 
hsa-miR-450a-1-3p 1.921 3.414E-03 2.765E-02 
hsa-miR-629-3p 1.511 3.446E-03 2.766E-02 
hsa-miR-485-5p -1.145 3.573E-03 2.842E-02 
hsa-miR-1273g-3p 1.661 3.631E-03 2.863E-02 
hsa-miR-598-3p -1.567 3.663E-03 2.863E-02 
hsa-miR-7641 1.958 3.854E-03 2.986E-02 
hsa-miR-543 -1.128 4.052E-03 3.112E-02 
hsa-miR-181b-5p -1.385 4.124E-03 3.140E-02 
hsa-miR-6720-3p -1.790 4.215E-03 3.183E-02 
hsa-miR-7706 -1.129 4.336E-03 3.237E-02 
hsa-miR-1252-5p -3.811 4.379E-03 3.237E-02 
hsa-miR-140-5p 1.180 4.396E-03 3.237E-02 
hsa-miR-221-5p 1.091 4.487E-03 3.277E-02 
hsa-miR-548am-5p 1.678 4.563E-03 3.306E-02 
hsa-miR-34b-5p 1.315 4.635E-03 3.331E-02 
hsa-miR-148a-5p 1.530 5.180E-03 3.692E-02 
hsa-miR-27a-5p 1.102 5.315E-03 3.758E-02 
hsa-miR-708-3p 1.873 5.375E-03 3.771E-02 
hsa-miR-3607-3p -1.284 5.485E-03 3.818E-02 
hsa-miR-374a-5p 1.135 5.543E-03 3.829E-02 
hsa-let-7d-5p -1.154 5.708E-03 3.891E-02 
hsa-miR-4707-3p -2.406 5.743E-03 3.891E-02 
hsa-miR-190a-5p 1.155 5.764E-03 3.891E-02 
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hsa-miR-1254 -1.364 6.095E-03 4.060E-02 
hsa-miR-1972 1.512 6.106E-03 4.060E-02 
hsa-miR-4521 -1.795 6.193E-03 4.087E-02 
hsa-miR-432-5p -1.086 6.298E-03 4.126E-02 
hsa-miR-18a-5p 1.135 6.548E-03 4.259E-02 
hsa-miR-30c-2-3p -1.086 7.089E-03 4.554E-02 
hsa-miR-106a-5p 1.507 7.105E-03 4.554E-02 
hsa-miR-655-5p -1.560 7.289E-03 4.639E-02 
hsa-miR-145-5p 1.205 7.524E-03 4.752E-02 
hsa-miR-1305 1.537 7.611E-03 4.752E-02 
hsa-miR-874-3p -1.231 7.627E-03 4.752E-02 
hsa-miR-374a-3p 1.046 7.849E-03 4.799E-02 
hsa-miR-3120-3p 1.233 7.853E-03 4.799E-02 
hsa-miR-3157-5p 1.941 7.863E-03 4.799E-02 
hsa-miR-675-5p 4.852 8.154E-03 4.942E-02 
hsa-miR-1180-3p -1.086 8.253E-03 4.968E-02 
 
